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1. Introduction
Cyanobacteria (or “blue-green algae”) are among the oldest known groups of organism on
Earth, with fossil records spanning approximately 3.5 billion years, and inhabit nearly every
ecological niche on the planet. In addition to their conspicuous occurrence as aquatic “blooms”
(e.g. visible scums on ponds and lakes; Fig. 1), as well as various colonial or macrophytic forms,
in marine and freshwater habitats, these photosynthetic prokaryotes are widely found in
terrestrial soils, and as part of numerous symbiotic relationships with a range of organisms
including animals, plants and fungi. To illustrate the extent of their global abundance and
importance, approximately 50% of all primary productivity, and related oxygen production,
occurs in the ocean, and the majority of this is derived from two genera of cyanobacteria,
Synechococcus and the picophytoplankton, Prochlorococcus (Ting et al., 2002). Likewise,
nitrogen-fixing cyanobacteria, and particularly the genus, Trichodesmium, are the largest source
of nitrogen in ocean systems (Carpenter and Romans, 1991). Moreover, several lines of
evidence (see, for example, Paerl and Huisman, 2009) point to an increase in the abundance,
distribution and persistence of cyanobacterial blooms in marine and freshwater system,
specifically driven by regional and global changes in climate (e.g. elevated water temperature,
stratification of the water column, changes in interseasonal weather patterns). The latter, in
particular, underscores the potential of cyanobacteria – and specifically toxin-producing
cyanobacterial blooms (discussed below) – as a rapidly emerging concern for public health.
Alongside their global biological importance, the cyanobacteria are widely recognized as
producers of a chemically diverse array of biologically active secondary metabolites (see, for
example, reviews by Gerwick et al., 2001; Tan, 2007; Tan, 2010). Considerable work over the
past four decades (see Tan, 2007) has, in particular, focused on exploring this chemical diversity
as a source of bioactive compounds with possible relevance to biomedicine, and specifically
© 2013 Berry; licensee InTech. This is an open access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
development of potential chemotherapeutics. Furthermore, a rather convincing body of
evidence (Proksh et al., 2002; Simmons et al., 2008) also suggests that many of the pharmaco‐
logically active marine natural products, originally isolated from various marine animal
sources – and including several currently either in clinical trials, or being commercially
developed as drugs - may, in fact, originate from cyanobacterial (or other microbial) sources
as a result of trophic transfer (e.g. herbivory, filter-feeding), and symbiotic or commensal
relationships.
Figure 1. Bloom of toxin-producing cyanobacteria on Lake Patzcuaro (Michoacan, Mexico), and subsistence fishing
occurring within the bloom. Photo courtesy of Alan Wilson (Auburn University).
In addition to their potential in biomedicine, however, a number of these bioactive metabolites
have been identified as naturally occurring toxins, and have been associated – as so-called
“cyanotoxins” - with various human and environmental health concerns. Perhaps most
notably, in freshwater systems, cyanobacterial populations can proliferate to the extent that
they form large “blooms,” typically manifesting as “films” or “scums” on lakes, ponds and
other freshwater systems (see Fig. 1). When comprised of toxin-producing representatives,
their occurrence is generally categorized as “harmful algal blooms” (HABs), or frequently as
“cyanoHABs” (to distinguish from similar blooms of several, unrelated, but likewise toxigenic,
marine microalgae). In particular, toxins from cyanoHABs - or even simply high abundance
of cyanobacterial cells – can contaminate water, and exposure to toxins via drinking water,
recreational exposure and related routes has been linked to various cases of human and animal
intoxication, as well as possible sub-acute and/or chronic health effects (e.g. increased rates of
certain cancers, effects on fetal development). As these direct routes of exposure are beyond
the scope of this chapter, and have been thoroughly covered by many previous authors, the
reader is direct to several good reviews on the topic (e.g. Rao et al., 2002; Stewart et al., 2006;
Funari and Testai, 2008).
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Although the vast majority of studies related to the health impacts of cyanobacteria have
focused on direct exposure to cyanotoxins via drinking water and related routes, there is a
growing body of evidence to suggest that toxic cyanobacterial metabolites can bioaccumulate
in aquatic food-webs, and may consequently pose additional health concerns as food-borne
contaminants. The relatively limited number of studies on food-borne cyanobacterial contam‐
inants may be attributed, in part, to the perceived lack of a mechanism for their bioaccumu‐
lation. Unlike more lipophilic contaminants, many of the recognized, water-soluble
cyanotoxins would, as such, not be expected to biomagnify by otherwise well-documented
mechanisms (i.e. storage, and subsequent transfer, in fatty tissues of animals) to higher trophic
levels most frequently consumed by humans. However, despite the lack of a clear means
transfer of these hydrophilic toxins in food webs, numerous studies have, indeed, demon‐
strated presence and apparent bioaccumulation in a range of trophic levels. Also likely limiting
the attention paid to cyanobacterial toxins in food-webs is the fact that best documented cases
of intoxication have been generally limited to direct exposure to these toxins, and specifically
acute human or animal poisonings with clear links to consumption of contaminated water, or
various related route, whereas there are - at present - few, if any, clear cases of recognized
human intoxication by food-borne cyanotoxin. That said, growing recognition that cyanobac‐
terial toxins may contribute to a sub-acute and/or chronic health effects – ranging from
increased rates of cancers, neurodegeneration and development toxicity - which are consid‐
erably more difficult to identify, would suggest that, despite the lack of currently documented
toxicoses, health threats posed by diet-derived toxins remains a very real concern.
The following chapter will present the current state of knowledge regarding the bioaccumu‐
lation of cyanobacterial toxins in the food web, and the possible role of these food-borne toxins
as it relates to human and environmental health. To begin, the chapter will present a brief
summary of the recognized cyanobacterial toxins, and their known toxicology and health
effects. Subsequently, the current evidence related to the bioaccumulation, trophic transfer and
bioavailability of these cyanobacterial toxins in food webs will be reviewed, along with related
methodologies (including methodological limitations and innovations) for investigating these
aspects. In addition to the widely recognized water-soluble cyanotoxins, cyanobacteria
produce a host of bioactive metabolites, including a number of lipophilic representatives.
Accordingly, the discussion will include a consideration of the less characterized bioactive
metabolites that, despite relatively unknown health effects, may represent – due to their
potential for biomagnification –relevant food-web contaminants. Finally, the chapter will
summarize the current state of knowledge regarding the impacts of cyanobacterial toxins as
it relates to human and environmental (i.e. ecosystem, animal) health.
2. Recognized cyanobacterial toxins: Chemistry and toxicology
2.1. Hepatotoxins
Detoxification of a wide range of toxic metabolites occurs - via multiphasic enzymes, and
associated processes (e.g cellular transporter and “pumps”) - in the liver or equivalent organ
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systems in animals. Accordingly, many toxic metabolites are actively transported (for subse‐
quent detoxification) to, and thus accumulate primarily in, hepatocytes. Not surprising,
therefore, two of the most commonly recognized cyanobacterial toxins are, in fact, associated
with hepatotoxicity. However, aside from active transport of these toxins to – and consequent
toxicity in - hepatocytes, it is becoming increasingly clear that the same metabolites may
accumulate in a range of tissues (even if not associated with acute toxicity in these cells), and
may – along with their generally uncharacterized toxicology in these tissues - be thusly
transferred to higher trophic levels.
2.1.1. Microcystins (MCs) and nodularin (NOD)
Perhaps the most widespread, and consequently well studied, of the cyanobacterial toxins,
microcystins (MCs) and nodularin (NOD) are, respectively, hepatotoxic hepta- and penta‐
peptide toxins. Both share structural similarity (Fig. 2), specifically characterized by a peptide
macrocyle incorporating common and unusual amino acids. However, the former (i.e. MCs)
represents a chemically diverse group of toxins, comprised of more than ninety variants
(Welker and Van Dohran, 2006). Although structural variation throughout the macrocycle
of the MCs has been reported, the primary differences occur in “X” and “Y” positions (Fig.
2), as per the accepted nomenclature for the group. As an example, the most common, and
generally  considered the  most  toxic,  of  these  variants  is  MC-LR in  which  the  X  and Y
positions,  respectively,  are  occupied by leucine  (L)  and arginine  (R)  residues.  Although
chemical variations exist, both NOD and most MC variants are characterized by a relative‐
ly well-conserved unusual  β-amino acid,  3-amino-9-methoxy-2,6,8-trimethyl-10-phenylde‐
ca-4,6-dienoic  acid  (Adda),  which  is  involved  (see  below)  in  the  toxicology  of  these
metabolites (Gulledge et al., 2003). Finally, whereas NOD is generally limited to a single late
summer blooming species, Nodularia spumigens, the MCs are produced by a taxonomically
wide  array  of  cyanobacterial  species  including,  most  notably,  the  widespread  species,
Microcystis  aeruginosa,  but  also  a  growing list  of  other  diverse  taxa  (e.g.  Aphanizomenon,
Oscillatoria, Planktothrix, Anabaena, Nostoc).
Toxiologically, both NOD and the MCs are inhibitors of Ser/Thr type 1 and 2A protein
phosphatases (PPases). Data generally suggest that Adda of NOD and MCs are involved in
the binding of the metabolite to the active site of PPases (Nishiwaki-Matsumishi et al., 1991;
Gulledge et al., 2003). To demonstrate this, several analogues of the MCs, specifically com‐
prised of only a single amino acid (i.e. Gly, or L- or D-Ala) coupled via peptidyl linkage to the
carboxylic acid of the N-acetylated Adda, were synthesized (Gulledge et al. 2003) and evalu‐
ated for toxicity. Although orders of magnitude lower than intact MC-LR, these analogs
retained substantial PPase inhibitory activity, suggesting that Adda significantly contributes
to the toxicophore of the MCs and NOD. On the other hand, the unusual amino acid, N-
methyldehydroalanine (Mdha), found in many MC variants has been shown to covalently bind
via a Michael addition to Cys273 of type 1/2A Ser/Thr PPases (MacKintosh et al., 1995). Ac‐
cordingly, it has been suggested that this distal (to Adda) amino acids is, therefore, also
involved in irreversible binding of the toxin to the PPase targets, as well as considerable
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underestimation of bioaccumulation (as a non-extractable “bound” form) in organisms
exposed to the toxin (see 4.2 Methodologies for evaluating cyanobacterial toxins in food-webs, below).
Figure 2. Chemical structures of hepatotoxic microcystins (A) and nodularin (B). In the former, structural variability is
primarily based on variation in the “X” and “Y” amino acid positions indicated; for reference, the common variant, MC-
LR, in which X and Y positions are leucine (L) and arginine (R) is shown.
Given the importance of PPases in a wide range of cellular functions, inhibition of these
enzymes, following exposure to NOD/MCs, can result in a range of acute toxicoses. Accumu‐
lating primarily in hepatocytes (i.e. liver) and associated organ systems, inhibition of PPase by
MCs and NOD most typically manifests as acute failure and hemorrhaging in these systems.
However, recent studies, specifically pointing to the presence of similar active transporters in
mammalian (e.g. rat) brains, have proposed a possible connection between MC uptake and
apparent inhibitory effects on short- and long-term memory (Maidana et al., 2006). Moreover,
emerging evidence supports an additional role of MCs in various chronic health effects, and
particularly, as recognized tumor promoters, increased rates of certain cancers. Most notably,
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studies in China (Yu, 1995; Ueno et al., 1996; Yu et al., 2001) have linked chronic exposure to
MC through ingestion of contaminated surface (i.e. ditch) waters to endemically high rates of
primary liver cancers. These studies suggest, in particular, that health concerns associated with
exposure to even quite low (e.g. sub-picogram per day) doses of cyanobacterial toxins, such
as MC/NOD, may promote negative health effects that might not clearly manifest as acute
intoxication. This may be particularly germane to discussion of the bioaccumulation of these
toxins since there have been to-date no known cases of overt intoxication from food-borne MCs
or NOD, whereas the possible long-term effects associated with chronic exposure to these
toxins (and others, e.g. BMAA) in the diet continues to present a possible concern.
2.1.2. Cylindrospermopsin (CYN)
Cylindrospermopsin (CYN) is a zwitterionic tricyclic alkaloid, specifically containing a unique
hydroxyuracil (Fig. 3). It was first identified following a relatively large intoxication event (the
so-called “Palm Island Mystery”) in Queensland, Australia. In this original case, children from
more than one hundred families on Palm Island, and nearby mainland community of Towns‐
ville, were stricken with severe gastroenteritis. Subsequent studies (Bourke et al., 1983;
Hawkins et al., 1985) linked the illness to the Solomon Dam – the primary water reservoir for
the community – and identified several bloom-forming species of cyanobacteria. Among these,
a toxic (in mouse bioassay) strain of the species, Cylindrospermospsis raciborskii, was identified
(Hawkins et al., 1985). More than ten years after the incident, CYN was identified as the toxic
principle of the C. raciborksii blooms in the reservoir (Ohtani et al., 1992), and following
subsequent stereoselective synthesis (Heintzelman et al., 2001), assigned the structure shown
in Figure 3. Originally thought to be a strictly tropical species, C. raciborskii, has been subse‐
quently shown to occur worldwide in both tropical and temperate freshwater systems,
possibly the result of recent expansion in its geographic distribution (Gugger et al., 2005).
Moreover, since its initial identification from C. raciborskii, CYN has been subsequently found
to be produced by several other members of the Nostocales, including the closely related
Aphanizomenon and Anabaena (Banker et al., 1997; Spoof et al., 2006; Preußel et al., 2006), as well
as at least one member of the Stigonometales (i.e. Umezakia; Harada et al., 1994), suggesting
relatively widespread production of the toxin.
Figure 3. Chemical structure of the hepatotoxin, cylindrospermopsin (CYN).
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Toxicological studies primarily suggest that CYN is an inhibitor of protein synthesis (Terao et
al., 1994; Froscio et al., 2001). Specifically, Terao et al. (1994) demonstrated ribosomal detach‐
ment (from endoplasmic reticula) in hepatocytes treated with CYN, and in vitro studies using
the rabbit reticulocyte translation system showed that CYN inhibits protein synthesis at
nanomolar concentrations (e.g. IC50 = 120 nM; Froscio et al., 2001). However, a range of possible
mechanisms of toxicity, and associated biomarkers of the toxin, have been additionally
identified and/or proposed. In accordance with inhibition of protein synthesis, Runnegar et al.
(1994, 1995) showed a reduction of the tripeptide, glutathione (GSH), in rat hepatocytes
exposed to CYN, particularly via apparent inhibition of GSH synthesis, leading to a presump‐
tive reduction in the detoxifying capacity of cells. Studies (e.g. Shaw et al., 2000; Humpage et
al., 2005) have similarly pointed to possible interaction of CYN with cytochrome P450, and
suggested a role of this detoxifying enzyme system. Based on structural similarity to nucleo‐
tides, specifically as guanidine alkaloid, and more specifically the hydroxyuracil moiety
contained in the tricyclic structure (Fig. 3), it has been suggested that CYN may additionally
exert toxicity by means of interaction with DNA and/or RNA. Indeed, CYN has been found to
form covalent linkages with DNA, leading to consequent chromosomal strand breakage (Shaw
et al., 2000; Shen et al., 2002), as well as other apparent genotoxic effects (Bazin et al., 2010).
This is notable as the uracil moiety of CYN has been shown as required for toxicity (Banker et
al., 2001). Finally, in vivo studies, particularly in the mouse model, point to a range of histo‐
pathological effects, particularly in cells of the liver, but additionally in several organ systems
(e.g. kidney, adrenal glands, lungs, intestines), following exposure via intraperitoneal or oral
exposure (Hawkins et al., 1985; Shaw et al, 2000; Humpage and Falconer, 2003). Moreover,
recent studies (in mice) show that long-term oral exposure to low-doses of CYN leads to
measurable effects (e.g. reduced hematocrit levels; Sukenik et al., 2006), and, likewise, exposure
to CYN during gestation induces fetal toxicity (Rogers et al., 2007), indicating that (similar to
MCs) sub-acute effects may occur with relatively low doses, but may be missed by simple
assessment of intoxication.
2.2. Neurotoxins
Several of the prominent cyanobacterial toxins are known to presumably cross the blood-brain
barrier, and have been consequently associated with neurotoxicity. Neurotoxic cyanotoxins
have been particularly identified based on observation of acute toxicity following exposure to
these toxins (see below). However, in at least one case (i.e. BMAA; see below), toxicity has been
associated with possible chronic neurodegeneration.
2.2.1. Anatoxin-a (ATX-a) and anatoxin-a(s)
Although chemically unrelated, two of the most active neurotoxins produced by cyanobacteria
are related both in name and mode of action. First identified from species of Anabaena,
anatoxin-a (ATX-a) is a tropane alkaloid (Fig. 4) with structural, but not pharmacological,
similarity to cocaine. In contrast, the relatively less common anatoxin-a(s), so-named due to
hyper-salivation associated with its neurotoxicity, is a phosphate ester of N-hydroxyguanine
(Fig. 4), likewise, isolated primarily from Anabaena spp. Although structurally very different,
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the two metabolites (along with a few chemically related variants, e.g. homoanatoxin-a) share
related toxicological mechanisms of action. Known as the “very fast death factor,” ATX-a and
its analogues are potent inhibitors of nicotinic acetylcholine receptors (nAChRs), specifically
mimicking the endogenous neurotransmitter, acetylcholine, whereas anatoxin-a(s) inhibits
related acetylcholinesterases (Aráoz et al., 2010). Interestingly, ATX-a is not degraded by
acetylcholinesterases, and thus irreversibly inhibits nAChRs (Aráoz et al., 2010). With regards
to food-webs, it should be noted that – compared to other cyanobacterial toxins – the “ana‐
toxins” are relatively unstable chemically, as well as being generally limited in their distribu‐
tion and occurrence, and thus rather few studies have reported their bioaccumulation (e.g.
Mejean et al., 2010; Osswald et al., 2011). That said at least one case of apparent bioaccumulation
of ANTX-a and its analogue (i.e. homoANTX-a) is, in fact, among the very few cases of acute
intoxications being possibly linked to food-borne cyanotoxins (see 3. Evidence for bioaccumula‐
tion of cyanobacterial toxins in aquatic food-webs, below).
Figure 4. Chemical structure of the neurotoxins, anatoxin-a (ATX-a, left) and anatoxin-a(s) (right).
2.2.2. Saxitoxin (STX) and “Paralytic Shellfish Toxins” (PSTs)
Potent inhibitors of voltage-gated sodium channels, saxitoxin (STX) and several chemically
related metabolites have been frequently associated with contamination of shellfish, and
consequent toxicity (i.e. “paralytic shellfish poisoning” [PSP]), as the so-called “paralytic
shellfish toxins” (PSTs). Specifically, in marine systems, the origins of STX/PSTs have been
identified as Alexandrium and several related species of dinoflagellates. However, in the late
1960s, apparent STX was identified (Jackim and Gentile, 1968) in the cyanobacterial species,
Aphanizomenon flos-aquae. Over the subsequent four decades, STX and related PSTs have been
identified from a wide range of cyanobacterial genera (e.g. Mahmood and Carmichael, 1986;
Humpage et al., 1994; Negri et al., 1995; Carmichael et al., 1997; Lagos et al., 1999; Beltran and
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Neilan, 2000; Pomati et al., 2000; Smith et al., 2011) including members of the Nostocales (e.g.
Anabaena, Scytonema, Cylindrospermopsin) and Oscillatoriales (e.g. Lyngbya, Planktothrix).
Figure 5. Chemical structure of saxitoxin (STX) and selected variants of the related “paralytic shellfish toxins” (PSTs).
STX/PSTs are potent inhibitors of voltage-gated sodium channels in neuronal cells, specifically
acting on (via binding to, and consequent blockage of) sodium passage through channel pores
(Aráoz et al., 2010). Inhibition of sodium channels, by blocking sodium influx involved in the
propogation of action potentials in neurons, leads to the aforementioned PSP syndrome which
manifests in a range of neurotoxic symptoms including numbness, tingling, weakness and
difficulty breathing as a result of the neuromuscular paralysis (Etheridge, 2010). Interestingly,
STX/PST binds to the nearly identical location as the equally potent neurotoxin, tetrodotoxin
(TTX), associated with poisoning by consumption of several species of pufferfish (Stevens et
al., 2011), and STX has, in fact, been identified alongside TTX in pufferfish (Nakamura et al.,
1984; discussed below). Notably, despite the identification of STX/PSTs from numerous
cyanobacteria species found in freshwater sytems, as well as apparent bioaccumulation of
presumptively cyanobacteria-derived toxin in fish and shellfish consumed by humans,
reported poisoning by the PSTs has been generally limited to ingestion of shellfish contami‐
nated by apparent marine dinoflagellate sources.
2.2.3. β-Methylamino-L-alanine (BMAA)
As perhaps the best studied case of apparent long-term toxicity resulting from a cyanobacterial
toxin bioaccumulated within food webs, the non-essential, non-protein amino acid, β-
methylamino-L-alanine (BMAA; Fig. 6) has been linked to high rates of the otherwise rare
amyotrophic lateral sclerosis (ALS), and possibly other related neurodegenerative diseases
(e.g. Parkinson’s Disease, Alzheimer’s Disease). Indeed, the first reports of BMAA as a
neurotoxic cyanobacterial metabolite specifically stemmed from studies of extraordinarily
high rates of ALS amont the indigenous Chamorro populations on the island of Guam. BMAA
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was originally identified as a plant-derived natural product, and specifically found in non-
flowering plants of the genus, Cycas (Vega & Bell, 1967). However, the origin of the metabolite
was ultimately traced to an endosymbiotic species of the cyanobacterial genus, Nostoc, found
within roots these cycads. The occurrence of BMAA in this cycad species (Spencer et al.,
1987), and its apparent biomagnification by fruit bats (or “Flying Foxes”) which consume the
fruits of the cycad, which are, in-turn, consumed as a delicacy by the Chamorro of Guam (Cox
et al., 2003; discussed below), has been suggested to provide a route of exposure to the
neurotoxin, and was consequently linked to ALS among the Chamorro. Indeed, subsequent
studies have accordingly identified both apparent biomagnification of the metabolite in this
rather short “food chain” (i.e. an approximately 104-fold increase from cyanobacteria to cycad
to fruit bat), as well as measurable levels of BMAA in the brains of Chamorro patients that
died from ALS and related syndromes (Cox et al., 2003).
Figure 6. Chemical structure of β-Methylamino-L-Alanine (BMAA).
Toxicologically, BMAA is a recognized agonist of glutamate receptors. Staton and Bristow
(1997) found that BMAA excited glutamate receptors, leading to apoptotic and necrotic cell
death, in cerebellar granule cells. Subsequent studies (e.g. Rao et al., 2006; Lobner et al., 2007;
Cucchiaroni et al., 2010) have confirmed a similar effect in a range of relevant neurons (e.g.
spinal motor neurons, cortical neurons, dopaminergic substantia nigra pars compacta cells).
More recently, however, it has been proposed that BMAA – as an amino acid – may become
erroneously incorporated via translation into proteins. One of the hallmarks of several related
neurodegenerative diseases (including ALS, Alzheimer’s Disease, Parkinson Disease/Demen‐
tia) is the formation of misfolded protein aggregates, and it has consequently been proposed
that the possible mis-incorporation of BMAA may represent an alternative mechanism of
action for this putative toxin.
Although first identified in the Chamorro/ALS case, potential health concerns associated with
BMAA have continued to grow with recent reports of a widespread occurrence of the metab‐
olite among cyanobacteria, and its bioaccumulation in a wide range of systems, as well as
additional epidemiological findings that link the compound to a complex of related neurode‐
generative diseases. In a study by Cox et al. (2005) chemical analysis of a wide range of
cyanobacteria, including marine, freshwater and terrestrial representatives, indicated that as
many as 95% of the genera produce BMAA, and pointed to a potentially widespread occur‐
rence of the metabolite. Since this study, the analytical techniques used with respect to BMAA
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have rapidly evolved (see 5. Methodologies for analyis of cyanobacterial toxins in food-webs, below).
Accordingly, several investigators (e.g. Li et al., 2012) have, in fact, argued - specifically based
on re-evaluation of the analytical methods previously used - that these prior estimates
regarding occurrence among cyanobacteria are perhaps exaggerated. However, despite this
standing controversy, a growing number of studies have concurrently pointed to the apparent
bioaccumulation of the metabolite in food webs and relevant human foods (discussed below)
which, along with increasing experimental evidence to support toxicological effects related to
neuronal and memory function (e.g. Karlsson et al., 2009 and 2009b; Liu et al., 2009; Purdie et
al., 2009 and 2009b; Karlsson et al., 2011), and links to additional clusters of these disease, have
continued to fuel emerging hypotheses regarding BMAA and neurodegeneration. With
regards to the latter, post mortem studies have identified BMAA in the brain tissues of patients
who had died from ALS and Alzheimer’s Diesease (AD), but not from either strictly hereditary
neurodegenerative disease (e.g. Huntington’s Disease) or unrelated causes (Pablo et al., 2009).
Several studies have, likewise, suggested links between BMAA and so-called “sporadic”
occurrence of these diseases ranging from Canadian AD patients (Murch et al., 2004) to clusters
of ALS associated with exposure to water blooms in New England (Caller et al., 2009) to
sporadic occurrence among Gulf War veterans purportedly exposed to BMAA through
cyanobacteria in desert dust (Cox et al., 2009). As these questions regarding occurrence of
BMAA among cyanobacteria, as well as its toxicological relevance, continue to be answered,
it is becoming clear that understanding the potential role of food-web bioaccumulation, as a
route of exposure to this metabolite, will be particularly critical.
3. Evidence for bioaccumulation of cyanobacterial toxins in aquatic food-
webs
Toxins from a number of marine HAB species – particularly including diverse eukaryotic
taxa  within  the  dinoflagellates  and  diatoms  (Bacilliariophyta)  –  bioaccumulate  and/or
biomagnify in marine food-webs, and have been clearly linked to contamination of fish and
seafood, and consequent intoxication of humans and wildlife (Van Dolah, 2000). Notably,
marine  algal  toxins  are  (1)  frequently  associated  with  commercially  important  seafood
species, including filter-feeding/grazing shellfish (e.g. clams, mussels) and several plantivo‐
rous  fish  species,  and/or  (2)  alternatively  characterized  by  relatively  high  lipophilicity
enabling uptake and storage in fat tissues as a means of biomagnifications to higher trophic
levels, including marine fish species eaten by humans (Van Dolah, 2000). Relevant exam‐
ples of the former include dinophysotoxins and various other metabolites associated with
“diarrhetic shellfish poisoning” (DSP), domoic acid associated with “amnesic shellfish
poisoning” (ASP) and contamination of shellfish by so-called PSP toxins (i.e. STX and other
PSTs, see above) derived from dinoflagellates (e.g. Alexandrium spp.). Examples of the latter,
on the other hand, include biomagnification of ciguatoxin, and several chemically related
lipophilic  metabolites  (e.g.  maitotoxin),  by  various  top-level  predator  species  of  fish  in
relation to the well documented “ciguatera poisoning.”
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Compared to marine HAB toxins, bioaccumulation of cyanobacterial toxins in food webs, and
its consequent relevance to human and environmental health, has been relatively much less
studied. There are likely several reasons for this. The most obvious is that, in contrast to the
well-documented contamination of fish and other seafood by marine algal toxins, there are
very few recognized cases of acute human or animal intoxication via consumption of bioac‐
cumulated cyanobacterial toxins. It is further proposed that this may be due, in part, to less
commercial fishing in freshwater water habitats - and thus consumption of freshwater fish and
shellfish - compared to marine fisheries. Indeed, a recent report by the United Nations’ Food
and Agriculture Organization (FAO) estimated the 2008 global fisheries catch as approximate‐
ly 90 million tonnes, but it was comprised of only a “record 10 million tonnes from inland
waters,” compared to more than 80 million tonnes from marine sources (FAO, 2010).
Regardless of the relatively limited focus on cyanobacterial toxins in freshwater fish and
shellfish, a growing body of knowledge – summarized in Table 1 – does, in fact, support
the occurrence of cyanobacterial toxins in a range of trophic levels, including species with
direct potential for human exposure, as well as possible implications for ecosystem health
(see 7. Implications for Ecosystem Health, below). Indeed, a number of thorough reviews on
the topic have recently appeared (e.g. Ibelings and Chorus, 2007; Ferrao-Filho et al., 2011;
Kozlowsky-Suzuki et al., 2012). Owing to the relatively polar (i.e. water-soluble) nature of
the recognized cyanobacterial toxins, it has been generally suggested that bioaccumulation
in the food-web will be limited to relatively “low” trophic positions. Indeed, in freshwater
food  webs,  this  has  included  particularly  high  rates  of  bioaccumulation  of  toxins  in
planktivorous  fish,  and  filter-feeding  or  other  grazing  invertebrates  (Table  1).  Reported
concentrations of accumulated cyanobacterial toxins are, at first glance, typically quite low
(Table 1). However, levels are obviously expected to vary - as shown in experimental studies
(e.g. Osswald et al., 2011) - with concentrations of toxins and/or algal cell density to which
animals  are  exposed.  Moreover,  it  is  suggested  by  various  studies  that  levels  may  be
sufficient for long-term (and consequently difficult to study) health effects, and that these
reported data (as discussed further below) may underestimate - due to limitations of typical
analytical  methodologies,  food  preparation  techniques  used  and  other  variables  -  the
possible contribution of these food-borne toxins.
From inspection of the available data on the accumulation of cyanobacterial toxins in fish and
shellfish (Table 1), it is clear that MCs are, by far, the most commonly reported. Indeed, MCs
are generally considered the most widespread of the freshwater cyanobacterial toxins.
Frequently, these data are reported in terms of “MC-LR equivalents,” as typical quantitative
analyses (e.g. ELISA, LC-MS) use this common variant as a reference standard, despite the fact
that as many as ninety variants have been reported (see Welker and von Döhren, 2006). In
addition to being among the most commonly detected of the microcystins, MC-LR is also one
of the most toxic variants (Zurawell et al., 2005). That said, studies suggest variability in the
uptake and detoxification of the variants. Xie et al. (2004), for example, studied MC-LR and
MC-RR distribution and depuration in phytoplanktivorous carp, and proposed, based on these
findings, a possible preferential uptake of MC-RR, or inhibited uptake of and/or active
mechanism to “degrade” MC-LR.
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Fish Toxin(s)a Tissue(s) Toxin
Conc.
(µg g-1)b
Reference(s)
Silverside (Odontesthes
bonariensis)
MC-RR Muscle 0.05 (mean)
0.34 (max)
Cazenave et al., 2005
Silver Carp (Hypophthalmichthys
molitrix)
MC-LR/RR
MC-LR (eq)
Muscle
Muscle
0.00025-0.097
0.0016
Chen et al., 2005
Shen et al., 2005
Carp (Cyprinus carpio) MC-LR (eq)
MC-LR (eq)
ATX-a
Muscle
Muscle
Whole
(juvenile)
0.038
0.005
0.005
Li et al., 2004
Berry et al., 2011a
Osswald et al., 2007
(experimental studies)
Goodea spp. MC-LR (eq) Muscle
Viscerac
0.157
0.867
Berry et al., 2011a
“Charales” (Chirostoma sp.) MC-LR (eq) Wholec 0.0185 Berry et al., 2011a
Redbreast Tilapia (Tilapia rendalli) MC-LR (eq) Muscle 0.002-0.337 Magalhaes et al., 2001
Nile Tilapia (Oreochromis niloticus) MC-LR (eq) Muscle 0.102 Mohammed et al., 2003
Blue Tilapia (Oreochromis aureus) CYN
STX/PSTs
Muscle
Muscle
0.00009
0.00003
Berry et al., 2011b
Topote (Dorosoma mexicana) CYN
STX/PSTs
Muscle 0.0008
0.0003
Berry et al., 2011b
Flounder (Platichthys flesus) NOD Muscle 0.0005-0.1 Sipia et al., 2006
Roach (Rutilus rutilus) NOD Muscle 0.0004-0.2 Sipia et al., 2006
Trout (Oncorhynchus mykiss) MC-LR (eq)
ATX-a
Muscle
Whole
(juveniles)
0.035
3.9-23.6
Wood et al., 2006
Osswald et al., 2011 (experimental
studies)
Yellow Perch (Perca flavescens) MC-LR (eq) Muscle 0.0008 (max)d Wilson et al., 2008
Unidentified species MC-LR (eq) Muscle 0.04 Magalhaes et al., 2003
NOD Muscle 0.0007-0.025 Van Buynder et al, 2001
Shellfish
Bivalves: Mussels
Anodonta woodiania MC-LR (eq) Muscle/foot
Wholec
0.009 (mean)
0.026 (max)
0.064
Chen & Xie, 2005a
Anodonta cygnea STX/PSTs Wholec 2.6 Pereira et al., 2004
(experimental study)
Alathyria condola STX/PSTs Wholec 57 Negri & Jones, 1995
(experimental study)
Hyriopsis cumingii MC-LR (eq) Muscle/foot
Wholec
0.022 (mean)
0.039 (max)
0.188
Chen & Xie, 2005a
Cristaria plicata MC-LR (eq) Muscle/foot
Wholec
(mean)
0.023 (max)
0.096
Chen & Xie, 2005a
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Fish Toxin(s)a Tissue(s) Toxin
Conc.
(µg g-1)b
Reference(s)
Lamprotula leai MC-LR (eq) Muscle/foot
Wholec
0.021 (mean)
0.058 (max)
0.131
Chen & Xie, 2005a
Mytilus galloprovincialis MC-LR
ATX-a
Whole
Soft tissuec
1.8 (max)e
0.006 (max)
Vasconcelos, 1995
(experimental study)
Osswald et al., 2008 (experimental
study)
Unidentified mussel species CYN Wholec 0.247 Saker et al., 2004
Unidentified mussel species NOD Wholec 2.5 Van Buynder et al., 2001
Gastropods: Snails
Apple Snails (Pomacea patula
catemacensis)
CYN
STX/PSTs
Wholec
Wholec
0.003
0.001
Berry and Lind, 2010
Crustaceans: Shrimp, Crab
and Crayfish
Crayfish (Procambarus clarkia) MC-LR (eq) Muscle 0.005 (mean)
0.010 (max)
Chen & Xie, 2005b
Red Claw Crayfish (Cherax
quadricarinatus)
CYN Muscle
Hepato-
pancreas
0.18f (mean)
0.86f (mean)
Saker & Eaglesham, 1999
Freshwater Shrimp (Palaemon
modestus)
MC-LR (eq) Muscle
Whole
0.006 (mean)
0.026 (max)
0.0114
Chen & Xie, 2005b
Freshwater Shrimp
(Macrobrachium nipponensis)
MC-LR (eq) Muscle
Whole
0.004 (mean)
0.012 (max)
0.051
Chen & Xie, 2005b
Unidentified crab species MC-LR (eq) Muscle 0.103 Magalhaes et al., 2003
Unidentified prawn species CYN
NOD
Muscle
Muscle
0.205
0.005-0.022
Saker et al., 2004
Van Buynder et al., 2001
a Total MC content frequently reported as MC-LR equivalents (“MC-LR(eq)” in the table).
b Toxin concentrations given as either range, or maximum (“max”) or mean (if not otherwise indicated).
c Fish or shellfish eaten whole including muscle and viscera. In the case of shellfish, shell or exoskeleton/carapace is
typically removed, and the inner flesh consumed.
d Converted from dry weight to wet weight using conversion factor of 5 as per U.S. EPA recommendation, assuming
~80% water content of fish (Holcomb et al., 1976).
e Conversion from dry weight to wet weight using conversion factor of 5.8 as per Ricciardi and Bourget (1998).
f Conversion from dry weight to wet weight using conversion factor of approximately 5 as per Headon and Hall (xxx)
Table 1. Measured concentrations of cyanobacterial toxins in freshwater fish and aquatic invertebrates eaten by
humans. Adapted, in part, from Ibelings and Chorus (2007).
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As shown in Table 1, concentrations of MC in these tissues are generally quite low, and might
imply a consequently low concern with respect to human exposure. However, there is evidence
– as discussed above - to suggest that chronic expoure to low levels of these toxins may pose
concern for long-term health (e.g. increased rates of cancer). Moreover, not shown in this table
is the generally higher accumulation of MCs by liver and associated organ systems due to
active transport of these toxins to hepatocytes and related cells (as discussed above). Although,
in the case of fish, in particular, muscle tissues (i.e. “flesh,” e.g. filets, etc.) are most typically
eaten, there are exceptions. Berry et al. (2011a), for example, evaluated the MC content (see
Table 1) of fish caught from a persistent cyanobacterial bloom in Lake Patzcuaro (Mexico), and
specifically reported considerable levels for those fish (i.e. “charales” and Goodea spp.) that are
locally eaten in their entirety, including muscle and associated viscera. Accordingly, these
results suggest that preparation technique can have a key role in assessing the potential for
human exposure.
Bioaccumulation, however, is not limited to the MCs, and a growing number of studies (see
recent review by Kinnear, 2010) have, for example, also reported variable levels of the
hepatotoxic CYN in relevant fish and shellfish species (Table 1). In fact, soon after the identi‐
fication of CYN as the toxin responsible for the Palm Island Mystery (Ohtani et al., 1992), Saker
and Eaglesham (1999) reported quite high levels of the toxin in both fish (“Rainbow Fish,”
Melanotaenia eachemensis) and invertebrate (i.e. “Red Claw Crayfish,” Cherax quadricarinatus)
species. Although, the former is not generally considered edible, the latter is, in fact, extensively
aquacultured as freshwater “seafood” commercially. Since that time, the potential for bioac‐
cumulation CYN has been reported in several field and laboratory studies (Norris et al.,
2001; Nogueira et al., 2004; White et al., 2006; White et al., 2007), although most have focused
on species not – or rarely (e.g. Swan Mussel, Anodonta cygnea; Saker et al., 2004) – eaten by
humans, and therefore, not generally relevant to human diet and health. As a notable excep‐
tion, Seifert et al. (2007) reported CYN from Eel-Tailed Catfish (Tandanus tandanus), an
omnivorous species of game fish; the toxin, however, was not detected in several other less
planktivorous species of fish (e.g. perch, bass). More recently, evaluation of CYN in the
endorheic lake system of Lake Catemaco (Mexico) identified the toxin in species of both finfish
(Berry et al., 2012) and relevant species of invertebrates (i.e. freshwater snails; Berry and Lind,
2010) consumed in this region.
Although not as well recognized (nor investigated), emerging evidence suggests that cyano‐
bacterial neurotoxins may also accumulate in relevant freshwater species (Table 1). With
regards to human health, STX and related “paralytic shellfish toxins” (PSTs) are – based on
their well-described association to intoxication via seafood – perhaps of most obvious concern.
STX/PSTs have widely documented as contaminants of marine shellfish, and particularly
bivalves, representing a recognized concern for public health (Van Dolah, 2000). More recently,
there have been increasing reports of STX/PSTs in fish, and particularly species of “pufferfish”
(Family Tetraodontidae), alongside the toxicologically related (i.e. voltage-gated sodium
channel blocking) tetrodotoxins that have been well described from these species. Similar to
contamination of shellfish, however, it has been recently shown (Landsberg et al., 2006) that
marine dinoflagellates (e.g. Pyrodinium spp.) are likely the source of STX/PSTs in the case of
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these typically estuarine fish. That said, studies (Negri and Jones, 1995; Pereira et al., 2004)
have shown that – like marine bivalves – freshwater mussels can also accumulate cyanobac‐
terially derived STX/PSTs. Although the mussel species (Alathyria condola) examined in these
studies (e.g. Negri and Jones, 1995) are not one typically eaten by humans (although frequently
by other animal species), more recent studies (Pereira et al., 2004) have measured considerable
levels of PSTs (fed via PST-producing Aphanizomenon issatschenkoi) in the Swan Mussel
(Anodonta cygnea) that, as previously mentioned, is occasionally consumed within certain
human populations in Europe and elsewhere. Even more recently, while evaluating the
apparent bioaccumulation of CYN associated with a bloom of C. raciborskii in Lake Catemaco
(Mexico), it was found that both edible “tegogolo” snails (Berry and Lind, 2010), and locally
consumed species of freshwater finfish (Berry et al., 2012), were found to accumulate STX/
PSTs. These studies, furthermore, point to a shared source of CYN and STX/PSTs, and
specifically C. raciborskii that is abundant in this lake system (Berry et al., 2012).
In addition to STX/PSTs, cyanobacteria are known to produce several other neurotoxic
metabolites, including (as discussed above) the toxicologically related ATX-a and anatoxin-
a(s). Compared to other cyanotoxins, the neurotoxic ATX-a is generally considered chemically
quite labile, and it is generally anticipated that the potential for bioaccumulation of this
unstable toxin would be, accordingly, rather low. That said, in experimental studies, it has
been shown that both fish – including trout (Oncorhynchus mykiss; Osswald et al., 2011) and
juvenile carp (Cyprinus carpio; Osswald et al, 2007) - and shellfish (e.g. mussel, Mytilus
galloprovincialis; Osswald et al., 2008) can, in fact, accumulate the toxin presented in either
dissolved (added to tank water) or cell-bound form. Moreover, in a recent study (Mejean et
al., 2010), bioaccumulation of this toxin in the giant clam (Tridacna maxima), frequently
consumed in the South Pacific, was evaluated in relation to several “ciguatera-like” intoxica‐
tion cases reported in the region, and found to contain the potently toxic analog, homoana‐
toxin-a, as well as possible traces of ATX-a. Though confirmation of these toxins, as the
causative agent of these reported poisoning, remains to be made, this study represents of the
very few examples of possible acute intoxication by a food-borne cyanobacterial toxin.
Similarly, despite the emerging picture of its biomagnification in terrestrial species (e.g. fruit
bats feeding on cycads; see above) over the past several decades, as well as the particularly
conspicuous abundance of cyanobacteria in aquatic systems, relatively limited attention has
been paid to the possible bioaccumulation of neurotoxic BMAA in aquatic food-webs. Several
recent studies (Jonasson et al., 2010; Brand et al., 2010; Mondo et al., 2012), however, have
suggested both accumulation, and possible biomagnifications of BMAA in marine systems,
including those species (i.e. fish, seafood) directly related to human health. In one very recent
case, the fins of several species of sharks, as “apex” marine predators, were examined, and
found to be laden with BMAA (Mondo et al, 2012), and consequently proposed to present –
via widespread consumption in the form of “sharkfin soup” – a potentially important route of
exposure to this toxin, and thus a public health concern, in Asian countries where shark fins
are considered a delicacy. Likewise, one of these studies, specifically evaluating BMAA in
South Florida waters, and more specifically including Caloosahatchee River, did, in fact, detect
this putatively toxic amino acid in both invertebrate (i.e. mussel) and fish species, including
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those consumed – at least occasionally - by humans (e.g. bass, bowfin, alligator gar) in this
freshwater system. Most interestingly perhaps, it was found in this, as well as concurrent
studies of marine food-webs, that measured BMAA levels were, in fact, higher in higher trophic
levels suggesting the possibility of biomagnifications of this metabolite. As a highly water-
soluble amino acid - with a low octanol/water-partitioning coefficient - it is not expected that
BMAA would biomagnify by conventional means (i.e. via deposition in fat bodies, etc.);
however, alternative mechanisms to this end are proposed (discussed below).
Finally, it bears mention that a growing number of studies have documented apparent uptake
of cyanobacterial toxins by various plant species via toxin-contaminated irrigation water.
Uptake of cyanobacterial toxins by plants was first suggested in a study by Pflugmacher et al.
(2001) that reported both uptake - and associated metabolism - of MC-LR by the water reed
(Phragmites australis). Subsequently, uptake and metabolism was similarly found to occur in
several agriculturally important species including various legumes, maize, wheat and alfalfa
(Peuthert et al., 2007). Similarly, it was recently reported that various cruciferous vegetables
(e.g. Brassica spp., Sinapsis alba) are capable of accumulating 10-21% of CYN provided to roots,
reaching as high as 49 µg/g (fresh weight) in the leafy components (Kittler et al., 2012).
Although not bioaccumulation per se (i.e. via trophic transfer), the rather high levels of these
compounds found in exposed plants, and specifically several agriculturally important crop
plant species, suggest that exposure to cyanotoxins through plant crops may pose a very real
public health concern.
Figure 7. Depiction of biomagnification (left) and biodilution (right) of toxins in food-webs.
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4. Trophic transfer and bioavailability of cyanobacterial toxins
Despite emerging evidence to suggest the bioaccumulation of cyanobacterial toxins within
food webs (as summarized above; Table 1), relatively little is known regarding the proc‐
ess of trophic transfer, and the subsequent bioavailability of “food-derived” cyanotoxins.
For  lipophilic  contaminants,  including  recognized  anthropogenic  pollutants  (e.g.  PCBs,
DDT) and even some HAB toxins (e.g. ciguatoxins), uptake and storage in fat tissues have
been largely implicated as a means of trophic transfer. However, there is no clear mecha‐
nism  for  bioaccumulation  and/or  biomagnification  of  the  most  widely  recognized  and,
moreover,  typically  water-soluble  cyanobacterial  toxins.  Likewise,  although  growing
evidence suggests that cyanobacterial toxins are, in fact, present in relevant components of
freshwater food webs (see section 3. Evidence for bioaccumulation of cyanobacterial toxins in
food-webs,  above),  a  very  limited  number  of  studies  have  investigated  whether  toxins
contained within ingested tissues are,  in fact,  released,  available and/or taken up in the
digestive process.  The following sections will  summarize the current state of knowledge
regarding both of these aspects.
4.1. Trophic transfer
As discussed in the previous section, a growing number of studies do, indeed, suggest that
cyanobacterial toxins are transferred via dietary/trophic transfer within aquatic food-webs. It
has been shown, in particular, that a range of phytoplanktivorous species, including zoo‐
plankton, fish, benthic grazers and filter-feeders consume toxin-laden algal cells, and directly
accumulate these toxins. Alternatively, it has been shown (Karjalainen et al., 2003) that certain
species, specifically including zooplankton, can accumulate, i.e. bioconcentrate, dissolved toxins
directly from water as might be found, in particular, during algal bloom senescence. However,
given the generally water-soluble (i.e. non-lipophilic) nature of the best known cyanobacterial
toxins (see 2. Recognized cyanobacterial toxins: chemistry and toxicology, above), as well as
currently available data on the apparent accumulation of these toxins within food webs (see
3. Evidence for accumulation of cyanobacterial toxins aquatic food-webs, above), it has been largely
argued that transfer of these toxins follows a trophic pattern of biodilution rather than biomag‐
nification (e.g. Ibelings et al., 2005; Ibelings and Chorus, 2007; Kozlowsky-Suzuki et al., 2012;
Fig. 7). In a very recent, and particularly thorough, meta-analysis of existing data by Kozlow‐
sky-Suzuki et al. (2012), it was shown that biodilution generally prevails. However, the authors
of this study do highlight several exceptions and related caveats with relevant implications
for potential exposure to toxins via food webs. Likewise, although concerns regarding human
exposure to aquatic toxins – particularly in freshwater systems – are most frequently focused
on higher trophic levels (i.e. sport and commercially caught fish species) as sources of toxins,
a growing number of studies (Ibelings and Chorus, 2007; Berry and Lind, 2009; Berry et al.,
2011; Berry et al., 2012) have documented accumulation of cyanobacterial toxins by species
from lower trophic levels (i.e. freshwater shellfish, phytoplanktivorous fish) that are, indeed,
consumed by humans, such that lack of biomagnification would not preclude possible human
dietary exposure.
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The potential for trophic transfer of cyanobacterial toxins is, generally speaking, controlled by
three interrelated factors: selection, chemical availability, toxin uptake and detoxification/elimina‐
tion (Fig. 8). Chemical availability will be discussed in the next section (4.2. Bioavailability). With
regard to the former (i.e. selection), this factor would be most likely expected to be limited to
initial consumption of toxin-producing algal cells by planktivores (that can subsequently serve
as vectors for the toxins). This would be expected since production of toxins by cyanobacteria
cells has been suggested to be linked to possible chemical defenses (i.e. feeding deterrency)
against potential grazer, and evidence (see below) does, in fact, suggest that toxins may deter
potential phytoplanktivorous grazers. As a corollary of this, it is suggested by this avoidance
that potential grazers are capable of “detecting” the presence of toxins in algal cells. On the
other hand, little or no evidence exists to suggest that toxin subsequent present in animal
tissues can be so detected, and thus it is generally assumed that selection further “up the chain”
is not a factor in higher trophic transfer. That said, other aspects of feeding behavior, including
both general feeding preferences/strategies (e.g. herbivory versus carnivory), and more
specific behaviors, particularly including selection of certain tissues by predators (e.g.
preference of human consumers toward fish muscle versus other organs/tissues), might be
argued to contribute to selection, and consequently the potential for trophic transfer.
A preponderance of evidence, in fact, supports a possible avoidance of toxigenic cyanobacteria
by phytoplanktivores. In particular, selectivity with regards to trophic transfer is perhaps best
demonstrated by numerous studies that have investigated feeding by zooplankton, and
particularly Daphnia spp., as a widespread cladoceran micrograzer, in relation to the MCs.
Microcystins have been shown to be toxic to Daphnia and other micrograzers, and toxicity has
been shown to specifically correlate with rate of ingestion of the toxin. However, subsequent
studies – specifically using “knock-out”non-toxic strains of Microcystis – have also, in contrast,
indicated that Daphnia may not have the ability to distinguish toxic versus non-toxic algal cells
(Rohrlack et al., 2001). Moreover, it has been generally found that interaction between grazers
and their cyanobacterial prey are dependent on class of grazer (e.g. micro- versus mesozoo‐
plankton), species and even inter-specific genetic differences (Kurmayer and Jüttner, 1999;
Davis and Gobler, 2011). More recently, it has been proposed (e.g. Wilson et al., 2005 and 2006;
Lemaire et al., 2012) that differences in the observed feeding deterrence, relative to toxin
content, may be explained by so-called “genotype x genotype interactions” whereby effects
on feeding behavior are determined by the combination of grazer genotype (e.g. tolerance or
susceptibility to toxin) and algal genotype (i.e. toxic or non-toxic). Finally, studies have
suggested (e.g. Kurmayer and Jüttner, 1999; Reinikainen et al., 2001) that avoidance of
potentially toxic cyanobacterial cells may be related to currently unknown, and particularly
lipophilic, metabolites rather than recognized toxins (e.g. MCs). Understanding of the role of
selection in trophic transfer, therefore, will rely on our increasing knowledge of genetic and
chemical variability of both cyanobacteria and their grazers.
Even if toxin-containing items are selected for ingestion, however, several lines of evidence
suggest both rather limited uptake of diet-derived toxin, as well as active and passive mech‐
anisms for detoxification and/or elimination of these toxins, which together would be expected
to limit the potential for trophic transfer. Understanding the contribution of these factors to
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trophic transfer, requires knowledge of – and/or means to investigate - the physiological,
cellular and possible molecular processes involved in both uptake and potential detoxification/
elimination. In the cases of MCs, for example, it has been suggested by multiple studies that
the gastrointestinal tract, and particularly mid-gut wall, of fish may be an important site for
toxin absorption (Chen et al., 2007; Dyble et al., 2011). Given the assumption that bioaccumu‐
lation is generally limited to lower trophic levels, it is not perhaps surprising, however, that
most insight in this regard has been, likewise, largely limited to phytoplanktivore models. In
order, for example, to evaluate the uptake (and subsequent elimination) of MC-LR by fish, in
relation to possible human exposure, specifically using the juvenile yellow perch (Perca
flavescens) model, Dyble et al. (2011) fed known doses of the toxin to fish orally via diet (i.e.
“toxin-doped” pellets), and determined concentration and distribution within relevant tissues
(i.e. muscle and liver) over time. Consistent with active transport of MCs to (for subsequent
detoxification in) hepatocytes, higher levels were found in fish livers, and kinetically speaking,
achieved a maximum level in liver cells (8-10 hours following dosing) prior to a subsequent
peak in muscle tissue (12-16 hours post-dosing). Moreover, the concentrations measured
represented orders of magnitude lower levels than those expected if the entire dose was
assimilated. Moreover, roughly equivalent concentrations were observed for two doses used
(5 and 20 µg), suggesting a possible maximum capacity for uptake. Furthermore, studies
showed a rapid increase in the toxin concentration (dependent in magnitude on dose)
following peak levels measured in the fish tissues (after approximately 10 hours), implying a
rather rapid elimination of the toxin by excretion (i.e. urine, feces). These finding support both
rather limited uptake, and rapid elimination of the toxin, however, it should be noted that
these data also correspond to a single dosing of the fish, whereas in aquatic habitats (i.e. during
blooms, or through persistent occurrence of toxic cyanobacteria) it would be expected that
possible grazers (and even other higher trophic levels) would be exposed more continuously
to toxins, such that the effective “window” of time for trophic transfer would be considerably
longer.
As pointed-out, the initial step for trophic transfer (from cyanobacterial cell to grazer) might
be expected to represent, in terms of selectivity, uptake and detoxification/elimination, a rather
distinct process compared to subsequent uptake by higher trophic levels. To understand this
higher-level transfer, therefore, it is necessary to evaluate the role of toxin derived from
primary consumer with respect to secondary (and subsequent) consumers. In a particularly
elegant example, Karjalainen et al. (2005) experimentally demonstrated uptake of NOD by
planktivorous fish larvae (i.e. Northern Pike) and invertebrate (i.e. mysid shrimp, Neomysis
integer) via pre-exposure of relevant zooplankton prey to the toxin both in pure form, and as
cell-free extracts of N. spumigens (as would be representative of the toxin released by decaying
blooms). Prior studies had shown that zooplankton accumulate NOD directly from water
(Karjalainen et al., 2003). In these subsequent studies, equal amounts of NOD (approximately
0.20 ng produced by an individual per 24 h) were detected in fecal pellets of pike larvae -
suggesting diet derived uptake and passage of the toxin - fed zooplankton exposed to both
pure toxin and NOD-containing extracts. Moreover, the authors of the study utilized radiola‐
beled NOD (i.e. 3H-dihydronodularin) to quantify the transfer of the toxin from zooplankton
to planktivores. Indeed, radiolabel was detected in both N. integer and pike larvae fed zoo‐
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plankton, previously exposed to 3H-NOD, with a maximum calculated accumulation of the
toxin at 12 h (0.31 ng/individual) and 48 h (0.47 ng/individual), respectively, for the two species.
Levels of NOD calculated based on these studies, however, were quite low (approximately
0.12% and 0.03%, respectively, for shrimp and fish larvae) compared to the amounts predicted
based on measured ingestion rate and concentration of toxin in zooplankton. These results are,
therefore, generally consistent with a proposed biodilution, rather than biomagnifications, of
this toxin within this food-chain. Furthermore, although ingestion rates were quite different
(i.e. more than 5-fold higher) for fish larvae compared to shrimp, both accumulated rather
similar levels (i.e. concentration per weight or individual) of the toxin. Accordingly, these
studies point to both a difference in the type of potential planktivore vector (i.e. fish versus
invertebrate systems), as well as a likely role of uptake and/or detoxification (and subsequent
elimination) of the toxin in relation to the observed biodilution.
In addition to understanding physiological, cellular and molecular aspects of potential grazers/
predators, uptake and detoxification can also be closely tied to the chemistry of the toxin.
Certainly, among the cyanobacterial toxins, the potential for uptake, and subsequent detoxi‐
fication/elimination, might be expected – due the chemically diverse nature of these com‐
pounds – to vary considerably with this chemical variability. This is most obviously
exemplified by the distinction of so-called “hepatotoxins” (e.g. CYN, MCs) that, as implied by
this classification, and unlike other cyanotoxins (e.g. PSTs, ATX-a, BMAA), are actively
transported via characterized organic anion transporter (OAT) proteins to hepatocytes for
subsequent detoxification/elimination. However, even with toxin families, variability in
uptake and elimination has been reported. For example, in studies on the uptake of MCs, Xie
et al. (2004) compared relative distribution following dosing with two common variants,
namely MC-LR and MC-RR, in phytoplanktivorous silver carp. Interestingly, dietary exposure
to MC-LR and MC-RR (in algal cells) resulted in considerably higher levels of the latter
distributed in various tissues, but rather limited tissue concentration/distribution of the
former, and more toxic, variant (Xie et al., 2004). Moreover, detection of relative amounts of
the two variants in gut and feces specifically supported an apparent barrier to uptake of MC-
LR, compared to the less toxic MC-RR (Xie et al, 2004). It should be pointed-out, however, that
results in this phytoplanktivorous model differ substantially from similar studies in a generally
carnivorous fish model, namely rainbow trout, particularly with respect to apparently rapid
uptake of MC-LR by the latter species, and consequently suggest a role of both consumer
species, and differential species physiology, relative to the potential for uptake (and subse‐
quent trophic transfer). Finally, uptake (and subsequent trophic transfer) may even be
determined, in part, by chemical presentation of the toxin. For example, it has been shown that
in a benthic grazer model, namely the snail, Lymnaea stagnalis, that MCs are more readily taken-
up from ingested cyanobacterial cells compared to dissolved toxin (Lance et al., 2010a).
Furthermore, concurrent studies comparing the fate of MC-LR presented in either dissolved
or cell-bound form (Lance et al., 2010b) suggested that, whereas no toxin from ambient/
dissolved dosings was found covalently bound in tissues, as much as 67% of cell-derived MCs
were accumulated via covalent binding (to targed PPase enzymes) representing a potentially
considerable reservoir of the toxin for subsequent trophic transfer (as discussed further below).
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The potential for trophic transfer is not likely limited to the most studied cyanobacterial
hepatotoxins (i.e. MCs). Although relatively few studies have evaluated their bioaccumula‐
tion, the transfer of the neurotoxic STX/PSTs, for example, has been studied with respect to
its accumulation in marine animals, and specifically in relation to non-cyanobacterially (i.e.
marine dinoflagellate) derived toxin. As a particularly important vector for PSTs, several
filter-feeding  mollusks  are  recognized  to  accumulate  toxin-containing  algal  cells,  and
represent a possible route for both direct exposure (i.e. “shellfish” consumption), as well as
possible  indirect  exposure  to  these  toxins  (i.e.  trophic  transfer  to,  and  consumption  of,
secondary consumers/vectors, e.g. fish). There is, in fact, emerging (albeit currently limit‐
ed) evidence to suggest that these neurotoxins may be transferred, to some extent,  from
filter-feeding invertebrates  to higher trophic  levels.  In particular,  however,  these studies
suggest that biotransformation via metabolism of PSTs – represented, as a group, by as many
as fifty variants (Wiese et al., 2010) - may be a critical consideration. In studies by Kwong
et al. (2006), black sea bream were exposed to green-lipped mussels, previously exposed to
the  PST-producing  dinoflagellate,  Alexandrium  fundyense.  Through  these  studies,  it  was
generally found that relatively little PST was transferred to the fish, and that the toxins were
rapidly  depurated  after  transferring  to  toxin-free  mussels.  Mooreover,  toxin  profiles
suggested  considerable  biotransformation,  and  particularly  conversion  of  C2  to  C1  var‐
iants  (see  2.2.2.  Saxitoxins  and  “Paralytic  Shellfish  Toxins,”  above).  Likewise,  subsequent
studies (Costa et al.,  2010) using white seabream, similarly exposed to PST-contaminated
cockles,  confirmed  the  rather  low  uptake  of  the  toxin,  and  additionally  reported  an
apparently  selective  uptake/elimination  and/or  biotransformation  such that  only  B1  and
dcSTX  were  found  in  fish.  This  conversion  and/or  selective  uptake/elimination  during
trophic  transfer  would  have  clear  implications  for  subsequent  bioavailability  of  this
neurotoxin, and associated health concerns, as there is considerable variability in the toxicity
of the PST congeners. Most generally, these studies point to the importance of the vectors
(e.g. fish versus shellfish) for the toxin.
Before moving on, to consider bioavailability, perhaps the one exception to the observed
pattern of biodilution, which consequently bears discussion, appears to be the trophic transfer
of BMAA. In the limited studies that have investigated BMAA in marine and freshwater food-
webs, it was shown, in fact, that levels of the toxic amino acid were higher for top trophic levels
(e.g. predatory fish) compared to lower trophic levels (e.g. Brand et al., 2010; Jonasson et al.,
2010). In a recent study, for example, Jonasson et al. (2010) examined BMAA within food webs
of the Baltic Sea, and reported a discernible positive correlation between levels of the toxin and
trophic level. It seems likely, though, that the pattern is not quite as simple as classic biomag‐
nification. For example, the Jonasson et al. (2010) and other studies (e.g. Brand et al., 2010) also
suggest particularly high levels for benthic versus pelagic species (of both vertebrates and
invertebrates). These studies also suggest differences in tissue distribution of the toxin with
highest levels of BMAA observed in brain compared to, for example, muscle, and, therefore,
underscore the importance of feeding ecology within food-webs, as well as the likely important
role of subsequent bioavailability (including uptake and metabolism) and tissue distribution
of toxins, in regards to trophic transfer.
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Figure 8. Factors affecting trophic transfer and bioavailabily of cyanobacterial toxins in food webs.
4.2. Bioavailability
Just as selection, chemical availability, uptake and detoxification/elimination would determine
trophic transfer of cyanobacterial toxins through food-webs, these factors are, likewise,
expected to primarily determine the bioavailability of these toxins to human as would be
ostensibly considered – with respect to the current discussion of emerging public health
concerns – the “top predator” in this regard. Although not perhaps, strictly speaking, a
“bioavailability factor” selectivity with respect to human consumption can certainly contribute
to the potential for exposure to food-borne cyanotoxins. In a general sense, several Tiers of
selectivity can dictate the likelihood of exposure (in concert with other bioavailability factors)
to cyanobacterial toxins in food. As mentioned previously, the generally limited consumption
of freshwater fish and shellfish, relative to much more common consumption of fish and other
seafood from marine sources, would be expected – given the recognized abundance of
cyanobacterial toxins in freshwater systems – to, likewise, generally limit the possible exposure
to these toxins. Even within freshwater systems, the relative consumption of fish and shellfish
species from lower trophic (i.e. phytoplanktivorous) levels of food webs would similarly
contribute to the possible exposure. However, as detailed above (3. Evidence for bioaccumulation
of cyanobacterial toxins in aquatic food-webs), there are certainly numerous documented cases of
toxin bioaccumulation by phytoplanktivorous species of freshwater fish and invertebrates (e.g.
snails, bivalves) which are, indeed, consumed by humans. Finally, even with species, and
particularly fish species, selectivity of certain tissues/organs can influence possible exposure
scenarios. Most notably, with respect to this latter tier, the general preference for fish flesh (i.e.
muscle) versus viscera (e.g. toxin-accumulating liver, etc.) has clear implications for the
potential for exposure to these toxins. Selectivity aside, however, the real issue of bioavaila‐
bility is clearly expected to be most closely linked to those biochemical and physiological
processes of digestion (i.e. uptake) and possible detoxification/elimination.
Cyanobacterial toxins, as discussed previously (see 2. Recognized cyanobacterial toxins: chemistry
and toxicology), have been traditionally classified based on their “target” organs. Specifically,
the most commonly studied cyanotoxins have been grouped into those targeting either the
liver/hepatocytes or brain/CNS, respectively, in the case of the so-called “hepatotoxins” (i.e.
MCs, CYN) and “neurotoxins” (i.e. STX/PSTs, ATX-a, BMAA). Based on both evaluation of
toxin distribution (e.g. high levels of MC and CYN in livers of exposed animals), and recog‐
nized manifestations of toxicity (e.g. neurotoxicity of STX/PSTs and ATX-a), following
exposure, effective bioavailability to these organs is largely assumed. In the case of the MCs,
however, active transport of the toxin to hepatocytes has actually been shown to be specifically
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facilitated by a family of organic anion transporter polypeptides (OATPs) that are particularly
abundant in these cells (Fischer et al., 2005; Lu et al., 2008; Fischer et al., 2010), and even
suggested to play a role in the selective uptake of certain MC congeners by hepatocytes (Fischer
et al., 2010). That said, OATPs are, in fact, found in other cell types, and it has been also been
suggested, for example, that OATPs in the brain may allow passage of MCs across the blood-
brain barrier (Fischer et al., 2005), and they have, accordingly, been linked to oxidative stress
in neurons, and subsequent effects on short and long term memory, caused by the toxin in a
rat model (Maidana et al., 2006). Although, likewise, considered a hepatotoxin, and found to
accumulate primarily in hepatocytes, the mechanism for CYN is not currently known. On the
other hand, studies of neurotoxic cyanotoxins have demonstrated the apparent ability of STX/
PSTs, ATX-a and BMAA to cross the blood-brain barrier (BBB) as a fundamentally limiting
step for all toxins that affect the CNS. For example, STX - as a representative PST - was detected
through brain tissues (from sacrificed animals), and consequently suggested to cross the BBB,
following both intravenous (Andrinolo et al., 1999) and intraperitoneal (Cervantes Cianca et
al., 2007) in mammalian (i.e. cat, rat) models. In support of the implied passage to - as suggested
by its purported toxicity, and measured presence in the brain - studies of BMAA, dating back
more than twenty years, and well prior to the recent resurgence of interest in this putative
neurotoxin, not only have shown that this unusual amino acid is capable of crossing the BBB,
but that transport might be specifically facilitated by large neutral amino acid carriers at the
blood-brain interface (Smith et al., 1992).
Although the potential for bioavailability of cyanobacterial toxins to target organs is implied
by their patterns of bioaccumulation, and observed toxic effects on certain organ systems, as
well as limited number of in vivo studies, most studies have focused on either exposure to
toxins via water ingestion, or in the case of laboratory studies, have examined fate of the toxin,
following intraperitoneal injection, or related forms of administering the toxin. The actual
bioavailability, with respect to foodborne toxins, is obviously limited by the prior chemical
availability (discussed further below), as determined by release (from food), uptake and
detoxification/elimination, prior to transport to target organs. To-date, however, studies on
uptake and detoxification/elimination of cyanobacterial toxins derived from foods are
essentially non-existent.
Rather, as with other aspects of health concerns regarding cyanobacterial toxins, the very
few studies that have considered bioavailablity of these toxins – and implicitly uptake and
detoxification/elimination as key factors -  have generally relied on data,  and subsequent
inferences,  extrapolated from water-borne cyanotoxins,  including dissolved or algal  cell-
derived toxins. Most notably, several authors have considered World Health Organization
(WHO)  guidelines  regarding  acceptable  concentrations  of  MCs  -  as  the  clearly  most
widespread  cyanobacterial  toxin  family  -  in  water,  and  subsequently  derived  guideline
values  for  total  daily  intake  (TDI)  of  this  toxin.  Values  of  TDI  are  generally  based  on
observed no or lowest observable adverse effect levels (NOAELs and LOAELs, respectively) from
very a very limited number of oral exposure studies in mouse and pig models (Falconer et
al.,  1994;  Fawell  et  al.,  1999).  Accordingly,  acceptable  values  for  lifetime,  one-time  and
occasional TDI have been estimated, respectively, as 0.04, 25 and 0.4 µg per kg body weight
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(Fromme et al., 1999; Ibelings and Chorus, 2007). In a particular thorough treatment, Ibelings
and Chorus (2007) extrapolated this to proposed guideline values that incorporate expo‐
sure via both water and food (and particularly “seafood”). Acknowledging a high variabil‐
ity in the amounts of food consumed, as well as other relevant factors (e.g. body weight),
the guidelines estimated in this way ranged greatly from 6 µg/kg for daily lifetime expo‐
sures to 1900 µg/kg for acute (i.e.  “one-time”) exposures for adults,  with corresponding
lower  values  for  children  (i.e.  0.08-250  µg/kg  body  weight).  That  said,  all  such  values
regarding intake (and,  implicitly,  the  necessary consideration of  subsequent  uptake and
detoxification/elimination)  are,  as  mentioned,  solely  based  on  (very  limited)  estimates
derived from oral exposure to a single toxin in water, and out of necessity, ignore bioavail‐
ability from a more complex “matrix” of animal tissues. Of course, as more information is
obtained with respect to the uptake, and subsequent detoxification/elimination, of toxins
from animal-based diet, it is hoped that a more realistic understanding of the potential for
food-borne exposure will emerge. In particular, a clearer understanding of these toxins in
relation to the dietary matrix, and consequently those factors (e.g. digestion, cellular uptake)
that determine fate is still needed.
Aside from considerations of uptake and subsequent detoxification/elimination, as it relates
to bioavailablity, it has become clear that, in certain cases, the potential (or lack thereof) for
human bioavailability may be considerably affected by chemical availability. This has been
specifically studied, to-date, in two cases: (1) irreversible, covalent binding of MCs to PPases
targets;  and (2)  erroneous  translation and consequent  incorporation of  BMAA into  pro‐
teins. In the latter case, for example, it has been suggested that BMAA, as a non-essential
amino acid, can be potential incorporated (via faulty translation mechanisms) into grow‐
ing protein chains. Specifically, investigating this possibility, Murch et al. (2004) analyzed
BMAA in cyanobacteria, and brains of patients who died of ALS/Parkinsonism dementia
complex (along with cycads and flying foxes from Guam as suggested vectors for the toxin),
both with and without prior acid hydrolysis. Measured levels of BMAA were on the order
of 10- to 240-fold higher following acid hydrolysis, suggesting an apparent release of this
amino acid  from proteins  in  these  samples.  This  finding,  therefore,  not  only  supported
incorporation of BMAA into proteins as a mechanism of toxicity (see 1. Recognized cyanobac‐
terial toxins: chemistry and toxicology, above), as well as possible limitations in the analytical
methodologies applied to this toxin (discussed further below; see Methodologies for evaluat‐
ing cyanobacterial  toxins  in  food-webs),  but  furthermore,  pointed to an “endogenous reser‐
voir” of the toxin. Such a reservoir would specifically provide a means of “slow release,”
of the toxin as possible mechanism for BMAA bioavailability, and would correlate with the
generally late onset of these diseases. It is, of course, implied from these studies that BMAA
bound in proteins in this way would, in fact,  be readily available following peptidolytic
digestion, however, this remains to be confirmed.
As  discussed  earlier  in  the  chapter  (see  1.  Recognized  cyanobacterial  toxins:  chemistry  and
toxicology),  MCs are  known to  bind to  PPases  found ubiquitously  in  cells  of  all  known
organisms. In addition, however, to reversible binding to the active site of PPases, it has
been shown (MacKintosh et al., 1995; Pereira et al., 2012) that the toxin, once in the active
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site, will form covalent bonds (via Michael addition) between the Mdha (present in many
MCs)  and  a  cysteine  (Cys273)  found  in  the  active  site  of  Ser/Thr  Type  1/2A  PPases.
Accordingly, it has been suggested that a portion of all Mdha-containing MCs might become
bound in this way (Williams et al., 1997a and 1997b; Yuan et al., 2006; Suchy and Berry,
2012), and indeed, estimates - based on specific analysis of the bound toxin (see 5. Method‐
ologies for analysis of cyanobacterial toxins in the food-web) - suggest a considerable pool of so
bound MCs. In classic studies by Williams et al. (1997a and 1997b), for example, analysis of
bound MC demonstrated that  as  little  as  24% of  MC administered (via i.p.  injection)  to
salmon could be recovered by conventional solvent extraction and analyses, and likewise
that as much as 10,000-fold more of the toxin, measured in Dungeness crab larvae, could be
detected in the presumptively “bound form” compared to the “free form.” More recently,
Hilborn  et  al.  (2007)  measured  both  free  and  bound  MCs  in  dialysis  patients  exposed
(through improperly treated water) to the toxin, and similarly measured significantly higher
levels when total (i.e. free and bound) levels were compared to those of the unbound toxin
(i.e. measured by solvent extraction and conventional detection, e.g. ELISA), and specifical‐
ly that only approximately 8-51% of MCs were measured by the latter method, compared
to the former.
A preponderance of evidence continues to suggest that bound MCs do, indeed, represent a
considerable pool of the toxin, however, very few studies have investigated whether these
bound MCs are, in fact, biologically available. To address this question, Smith et al. (2010)
recently investigated the potential for digestive enzymes to release covalently bound MC
from PPases. Whereas digestive proteases (e.g. trypsin, chymotrypsin, pepsin) were found,
as expected, to effectively hydrolyze a control protein (i.e. angiotensin), they had no effect
on the cyclic peptides (i.e. MC-LR and MC-LY). Furthermore, based on the assumption that
protein-bound MCs could be partially released by these peptidolytic enzymes, the investiga‐
tors synthesized four Cys-containing MC-oligopeptide adducts,  specifically predicted for
hydrolytic digestion of the PPase active site by these enzymes, and subsequently evaluat‐
ed them for toxicity (i.e. inhibition of protein phosphatase). Although inhibition was reduced
(compared to MC-LR alone) to approximately 58% for MC-peptide adducts - composed of
the cyclic MC-LR covalently bound, via cysteine, to predicted tetra- and nonomeric peptide
fragments - this residual biological activity supports the possible bioavailability of potential‐
ly  toxic  bound MCs following protein  hydrolysis  in  the  digestive  system.  Interestingly,
concurrent studies (Zhang et al.,  2010) evaluated the effects of cooking as an alternative
mechanism for release of covalently bound MCs with respect to potential availability of the
toxin.  In  these  studies,  it  was  specifically  found that  levels  of  MC-LR in  carp  (injected
intraperitoneally with the toxin) were significantly higher (approximately 4-fold) in both
muscle  tissue  and  water  following  boiling,  compared  to  lyophilization  and  subsequent
solvent extraction only, and it was suggested that elevated levels were due to release of
covalently bound toxin from these tissues. Although such studies do point to the possible
chemical availability of covalent bound toxins, clearly further studies are needed to fully
elucidate the possible bioavailability of these in relation to human exposure.
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5. Methodologies for evaluating cyanobacterial toxins in the food-web
Techniques for chemical detection and quantitative analysis of cyanobacterial toxins have
evolved alongside recognition of their potential health impacts. The majority of the previously
established analytical methods (e.g. HPLC-UV, LC-MS, ELISA) have, therefore, primarily
focused on the identification of toxin in algal cells and/or dissolved in water, with water (i.e.
contamination of drinking water, recreational exposure) being an established direct route of
exposure. As for these applications, analytical techniques applied to measurement of toxins in
food webs have, likewise, generally focused on two approaches (Sivonen, 2008; Humpage et
al., 2010). The first, and arguably most common - given the complex nature of these biological
matrices (discussed further below) - has included a number of so-called “hyphenated meth‐
ods” in which analytical separation, including liquid chromatography (LC) and capillary
electrophoresis (CE), in particular, are coupled to one or more suitable detection/measurement
technique, including UV absorbance, fluorescent derivatization/detection (FL), mass spec‐
trometry (MS) and electrochemical detection. Alternatively, with the relatively recent com‐
mercial availability of enzyme-linked immunosorbent assay (ELISA) kits for several
cyanobacterial toxins, as well as growing understanding of the toxicology of these metabolites
- and thus development of several biochemical techniques (e.g. protein phosphatase inhibition
assays for MCs) - these bioanalytical techniques have been also applied to the evaluation of
cyanobacterial toxin in relation to food-webs and bioaccumulation (e.g. Lance et al., 2006; Berry
and Lind, 2010; Berry et al., 2011; Berry et al., 2012). However, unlike detection of several non-
cyanobacterial, marine algal toxins as contaminants of fish and seafood for which there are
validated analytical techniques, there are presently no validated methods for evaluating
cyanobacterial toxins in biological matrices.
Both of the aforementioned approaches present potential limitations, but generally speaking,
it would be argued that the two consequently complement one another. In particular, ELISA-
based methods have been somewhat criticized (Metcalf et al., 2000; Mountfort et al., 2005) as
being potentially susceptible to non-targeted molecules (i.e. matrix components) in samples
that may immunologically cross-react with antibodies, or alternatively not being able to
distinguish more toxic variants among co-occurring congeners within toxin groups. As
antibodies used in ELISAs are typically generated in relation to a particular representative
variant of these toxins, relying on chemical similarity and cross-reactivity to detect other
variants, they do not enable co-occurring congeners to be distinguished from total toxin
concentrations. This latter limitation is perhaps best exemplified by the ELISA-based analysis
of MCs. Although commercially available ELISAs for MCs exploit the generally conserved
Adda moiety found in most variants (Fig. 2), MC variants lacking (or containing modified
versions of) Adda have been reported (Namikoshi et al., 1990 and 1992; Sivonen et al., 1992;
Oksanen et al., 2004), and would be missed in these analyses leading to some degree of “false
negatives,” or at least possible underestimation of MC content. Alternatively, studies have
shown that improper use of ELISA kits – as well as factors such as organic solvents, salinity
and pH - can contribute to the potential for false positives (Metcalf et al., 2005). Additionally,
it is recognized that toxicity of MCs varies with congener, and therefore the inability to
distinguish particular variants, with respect to this relative toxicity, does not enable what is
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essentially a proxy of “total MC” to be evaluated in terms of actual relevance to toxicity
(Mountfort et al., 2005). As an alternative, enzyme assays - and particularly the various PPase
inhibition assays developed for MCs (Mountfort et al., 2005) – are, in fact, capable of assessing
cyanobacterial toxins based on relevant biological activity. However, such assays are typically
not as sensitive as, for example, ELISA, and likewise may be susceptible to matrix components,
as well as being unable to chemically distinguish particular toxin variants. That said, sensitivity
of methods such as ELISA are generally higher than for most other methods, and moreover,
although coupling analytical separation to detection (e.g. LC-MS) may enable identification of
particular chemical variants, this is only applicable to those variant which are specifically
targeted. In other words, even though LC coupled to tandem mass spectrometry (MS/MS) can,
for example, selectively detect several common MC variants based on characteristic molecular
ions, and subsequent “daughter ions,” without prior knowledge of the optimal parameters
(i.e. parent/daughter ions, ionization energy, etc.) - and/or availability of suitable analytical
standards - to use for other for other less common (or perhaps yet uncharacterized) variants,
and their metabolic products, these would be generally missed by such an approach (Mount‐
fort et al., 2005). Accordingly, a strategy which incorporates both approaches and their relative
benefits (i.e. highly sensitive detection of “total” MC by ELISA, target-based bioassay and
selective analytical separation and detection of individual MC variants) might be expect to
provide the most comprehensive toxin profile.
In general, the obvious challenge posed in adapting analytical techniques, originally devel‐
oped for water (and, to a lesser extent, algal) samples, to bioaccumulation in food webs is the
relatively more complex matrix of biological specimens (i.e. animal tissues). Other components
of these biological matrices can interfere with analyses by specifically requiring a higher degree
of selectivity (to discern the analyte from other components of the matrix), and as well as
leading to suppression of the detection response (e.g. suppression of ionization in MS). To
some extent, these challenges are inherently addressed when coupling detection to optimized
analytical separation (e.g. LC-MS) that essentially isolates components (e.g. as chromato‐
graphic peaks based on retention time, etc.), but has also been generally supplemented by
sample preparation steps prior to analysis. In particular, sample preparation steps have
included selective extraction (e.g. Metcalf et al., 2002; Msagati et al., 2006), solid-phase
extraction (SPE; e.g. James et al., 1998; Metcalf et al., 2002; McElhiney and Lawton, 2005; Scott
et al., 2009) and other so-called “clean-up steps” to remove these potential interfering chemical
species. Of course, in the case of less stable toxins (e.g. ATX-a; discussed below), extensive
sample work-up can chemically jeopardize the analyte leading to underestimation or even
complete non-detection of these compounds; generally speaking though, most approaches
require some degree of sample preparation prior to analysis, particularly when dealing with
complex bio-matrices.
One of the particular challenges of a biological matrix is due to the lack of specificity of certain
detection methods. For example, although none of the recognized cyanobacterial toxins
discussed have a particularly specific chromophore, as to enable unambiguous detection,
HPLC coupled to UV spectrophotometric detection has been successfully used – specifically
based on shortwave UV detection and established chromatographic retention time, and in
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conjunction with analytical standards – to detect and measure several cyanobacterial toxins in
water samples (e.g. Harada et al., 1994; Gugger et al., 2005; McElhiney and Lawton, 2005; Berry
and Lind, 2010). However, in more complex bio-matrices, this lack of a distinguishing UV
chromophore, and potential for co-eluting non-targeted components of the matrix generally
limit this approach. Similarly, although fluorescence derivatization – and subsequent fluores‐
cence detection coupled to chromatography or other analytical separation techniques (e.g. CE)
- has been used as a highly sensitive means of detection/measurement of cyanobacterial toxins
(e.g. Harada et al., 1997; James et al., 1998), the derivatization chemistry frequently employed
in these approaches exploit common functional groups (e.g. amines, carboxylic acids, dienes).
As such, non-toxin analytes (e.g. peptides) present in biological matrices can be coincidentally
derivatized and, by co-elution and/or simply poor resolution, interfere with identification of
the analyte of interest. Possible overlap in analytical response is not limited to these analytical
separation/detection techniques, and indeed, it has been suggested that for ELISA, antibody
cross-reactivity with chemically related components of the matrix might, likewise, lead to non-
selective detection, and erroneous results in analyses.
Even in the case of highly selective detection techniques, interference due to the bio-matrix
can arise. This is particularly seen with quantitative analyses based on mass spectrometry,
including LC-MS, and particularly the most commonly used (at present) method of electro‐
spray ionization (LC-ESI-MS). Components of the sample matrix, including inorganic (e.g. pH,
salts/ions) and organic (e.g. proteins and other biomolecules) components, can both interfere
with ionization; the former can directly interfere with ionization, whereas the latter can
indirectly effect ionization of the analyte, particularly through competitive ionization. In the
case of MCs, for example, it has been shown that dissolved organic carbon, pH and ionic
strength can suppress signal in LC-MS with the latter being the most significant (Li et al.,
2010). More notably in relation to the present discussion, Karlsson et al. (2005) investigated the
effect of a biological matrix with respect to the LC-MS detection of MCs and NOD in biological
tissues, including aquatic invertebrates (i.e. Blue Mussels, Mytilus edulis), fish (i.e. Rainbow
Trout, Onchorhyncus mykiss) and waterfowl (i.e. Common Eider, Somateria mollissima). In these
studies, it was found that ion signal varied from 16-134% of the expected signal (from spiked
toxin), suggesting a good deal of both ionization suppression and enhancement, which varied
with toxin variant (i.e. six MC variants and NOD) and biological matrix. In related studies,
investigating the use of an MC oxidation product (discussed below) for LC-MS analysis, Ott
and Carmichael (2006) reported losses in signal strength of more than 41% for this analyte.
More recently, Li et al. (2012) examined the effects of ionization suppression with respect to
quantitative analysis of BMAA, as well as its non-toxic isomer, 2,4,-diaminobutyric acid (DAB),
by LC-MS/MS. Although considerable matrix effects were observed for DAB, there appeared
to be no contribution to the BMAA signal. Notably, however, this optimized method was used
to suggest that BMAA was not seemingly present in several cyanobacterial samples evaluated,
and to support the growing indication that this putative toxin is not as widespread as previ‐
ously suggested. Indeed, although matrix effects represent an analytical challenge, the effects
of signal suppression (e.g. ion suppression) can generally be addressed by various strategies,
including the use of appropriate internal standards and techniques of standard addition to assess
the extent of this effect on quantitation.
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Limitations Advantages
Biochemical Methods
ELISA Cost (~$400-500/plate)
No chemical information, e.g.
identification of chemical variants
No toxicity information
Highly sensitive (< ppb)
Rapid/analyze multiple samples at
once
Easy/little training required
Relatively inexpensive
instrumentation (i.e plate readers)
“Target-Based”
e.g. PPase inhibition
No chemical information, e.g.
identification of chemical variants
Somewhat lower sensitivity
Low selectivity, e.g. false positives
Provides toxicity information
Relatively inexpensive (reagents)
Rapid/analyze multiple samples at
once
Easy/little training required
Relatively inexpensive
instrumentation (i.e plate readers)
Instrumental Analysis
(i.e. analytical separation/detection)
HPLC/CE-UV Low sensitivity
Low selectivity, e.g. false positives
Requires training
Limited chemical information, e.g.
can’t identify unknown variants
Moderately expensive
instrumentation
Relatively slow/can’t analyze
multiple samples at once
Requires sample clean-up
Provides some chemical information,
e.g. can identify chemical variants (if
standards available)
Analysis can be automated
HPLC/CE-FL Requires derivatization
Somewhat low selectivity, e.g. false
positives
Requires training
Limited chemical information, e.g.
can’t identify unknowns
Moderately expensive
instrumentation
Relatively slow/can’t analyze
multiple samples at once
Requires sample clean-up
Highly sensitive
Provides some chemical information,
e.g. can identify chemical variants (if
standards available)
Analysis can be automated
HPLC/CE-MS Requires training
Expensive instrumentation
Relatively slow/can’t analyze
multiple samples at once
Requires (some) sample clean-up
Provides chemical information, e.g.
can identify chemical variants (if
standards available), possible
information regarding unknowns
Analysis can be automated
Table 2. Limitations and advantages of different analytical techniques used for detection/measurement of
cyanobacterial toxins.
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Aside from issues specifically related to the complex biological matrices encountered in food
webs, some of the same general challenges associated with quantitative analysis of cyanobac‐
terial toxins in water are, likewise, associated with analysis of bioaccumulation. A common
consideration, in this regard, includes a requirement of selectively to detect, and discern,
isomers and chemically related congeners. Indeed, this is exemplified by all of the recognized
cyanobacterial toxins. For example, both PSTs and the MCs belong to rather large families of
chemically related, but structurally distinct, variants – specifically represented, at present, by
as many as fifty, and more than ninety, reported variants, respectively - with equally variable
toxicity for each. In both cases, especially toxic and common variants (i.e. STX and MC-LR) are
most frequently considered as a proxies for these toxin families, however, it is known that
several other congeners from these groups can, in fact, potentially contribute to toxicity, and
moreover, due to differential uptake and bioavailability hold, likewise, variable potential with
respect to bioaccumulation. This presents, as discussed above, a clear limitation to ELISA-
based analyses of the MCs that is unable to distinguish specific contributions of individual
congeners. Likewise, although LC-MS and related methods, which employ analytical separa‐
tion prior to detection, are able (if sufficiently optimized) to chromatographically resolve/
separate congeners, the requirement for established molecular ionization and fragmentation
parameters to detect these variants (by mass spectrometry) limits which variants will, and will
not, be detected. Although considerably less complex, on the other hand, both CYN and ATX-
a, likewise, have structurally related congeners and/or structural isomers, including for
homoATX-a and 7-epiCYN, respectively, that are found alongside the “primary” toxins. In
both of these cases, the congeners are also associated with toxicity, and evaluation of their
contribution with respect to food-borne toxins needs to be included. On the other hand,
although only BMAA (among several structural isomers) has been reported as potentially
toxic, it has been suggested that natural occurrence of numerous possible isomeric congeners,
all sharing the same molecular mass (Fig. 9), may greatly confound mass spectrometric analysis
of this toxic amino acid (Banack et al., 2010), and specifically it has been suggested that, due
to this, the once considered widespread occurrence of this neurotoxin may, in fact, be consid‐
erably over-estimated (Jiang et al., 2012; Li et al., 2012).
Although many of the cyanotoxins are generally considered chemically quite stable, and thus
persistent in the environment, stability has, likewise, been suggested to limit quantitative
analysis in some cases - and particularly ATX-a as perhaps the most chemically labile of the
known toxins from cyanobacteria. Indeed, ATX-a has an estimated (Stevens and Krieger,
1991) half-life of only about 1-2 days – or even as low as 4-10 hours - in solutions emulating
relevant biological conditions, including sunlight (i.e. photolysis) and pH (i.e. acidification).
Degradation products, moreover, are generally not considered toxic (Stevens and Krieger,
1991). This instability poses obvious challenges, and particularly the potential for this toxin
being underestimated or even missed in chemical analyses, and may, in fact, contribute to the
absence of any reports on its bioaccumulation in food webs. Accordingly, it is generally
advised that appropriate precautions regarding sample collection, transport and storage be
taken to minimize recognized factors (i.e. light exposure, pH), and methods have been
developed to increase speed of analysis (e.g. Smith and Lewis, 1987), to minimize this factor
in assessing the possible role of ATX-a in relation to food-borne health concerns.
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Figure 9. Isomers of the toxic amino acid, BMAA, suggested to potentially confound MS analysis.
As we learn more about the fate of cyanobacterial toxins in food webs, it is becoming increas‐
ingly recognized that at least two of the recognized cyanotoxins, namely MCs and BMAA, may
present specific analytical challenges due to their specific chemical toxicology. As previously
discussed (see 4.2 Bioavailability), in addition to reversible binding of the MCs to “targeted”
PPases, covalent and thus effectively irreversible binding of these toxins, specifically via Mdha
(Fig. 10), may lead to considerable underestimation of the total MC content as quantitative
chemical analyses based on solvent extraction, and subsequent detection of the non-bound
molecule, would generally miss these bound-forms of the toxin. Indeed, it has been estimated
that more than 75% of MC-LR (as representative Mdha-containing variant) in exposed fish,
and as much as 99.9% in exposed invertebrates (e.g. mussels), is effectively “tied up” by
covalent, irreversible binding (Williams et al., 1997a and 1997b). Similarly, as also discussed
previously, one of the proposed mechanisms of toxicity for BMAA is erroneous incorporation
into proteins, leading to aberrant protein aggregates which are hallmarks of neurodegenera‐
tive disease (e.g. ALS, Alzheimers’ Disease) linked to this toxic amino acid. Accordingly, this
bound pool of the amino acid would not be immediately available to subsequent analyses
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relying solely on solvent extraction from the biological matrix. Considering this, several recent
developments have focused on analytical strategies for including these “bound-forms” of the
toxins in the overall assessment of their contribution to food-web bioaccumulation.
Figure 10. Lemieux oxidation of MC-LR, and detection of product (MMPB) as a surrogate for total MCs.
Perhaps the most elegant of these has been the development of the so-called “MMPB method,”
based on detection of the Adda oxidative cleavage product, 3-methyl-4-methoxy-phenylbu‐
tanoic acid (MMPB), as a proxy for total (i.e. bound and unbound) microcystins. As stated
previously, Adda is both a key component of the MCs with respect to their toxicity, and is,
indeed, conserved in the vast majority of variants (Fig. 2). Taking advantage of this conserved
moiety, Sano et al. (1992) developed an analytical technique, specifically based on Lemieux
oxidation that utilizes permanganate/periodate oxidation to cleave MMPB from the pendant
Adda of microcystins (Fig. 10). This analyte can be subsequently quantified by several
techniques, including GC-MS (Sano et al., 1992; Williams et al., 1997a and Williams et al.,
1997b; Suchy and Berry, 2012) and LC-MS (e.g. Ott and Carmichael, 2006; Yuan et al., 2006).
As Adda is distal to the Mdha, and site of covalent linkage to the PPase active site, the liberated
MMPB can be used as a proxy – with no otherwise known naturally occurring counterpart –
for both bound and free MCs. In fact, when subsequently applied to a range of fish and
invertebrates, it became clear both that a the vast majority of MCs in exposed animals are not
detected by analytical methods based on solvent extraction of the free toxin (suggesting a
considerable loss of the exposure dose), and that significantly more of the toxin were detectable
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by the MMPB method (suggesting covalent binding as a likely “sink” for this lost toxin).
Williams et al. (1997a and 1997b) most famously applied this method to the analysis of
experimentally (i.e. intraperitoneally) exposed salmon, as well as samples of Dungeness crab
larvae and mussels (Mytilus edulis). In these studies it was found, for example, that while nearly
100% of exposure dose (from Microcystis cells) could be recovered by the MMPB method, only
approximately 0.1% of MC of the expected levels were detected by MeOH extraction coupled
to a PPase inhibition assay (Williams et al., 1997a). Likewise, for i.p.-exposed salmon, approx‐
imately 34% recovery of MC by Lemieux oxidation, specifically coupled to GC-MS, was
reported, compared to approximately 8% recovery for MeOH extraction and PPase inhibition
assay, and similarly more than 10,000-fold higher MC was detected by the MMPB method
compared to extraction/PPase inhibition in populations of crab larvae (Williams et al., 1997b).
More recently, the modified MMPB method (i.e. SPME-GC-MS detection of MMPB) was
applied to evaluation of MCs in several fish species, including those consumed by humans,
from various freshwater lake systems, and it was similarly found that this approach measured
significantly higher levels of the toxin (5- to 40-fold higher) than those detected by ELISA
(Suchy and Berry, 2012). Since initial development of the technique, the MMPB has been further
refined to include improvements in the sample preparation steps, including SPE (Ott and
Carmichael, 2006) and solid-phase microextraction (SPME; Suchy and Berry, 2012), as well as
subsequent detection methods (e.g. LC-MS, and LC-MS/MS, versus GC-MS; Ott and Carmi‐
chael, 2006; Yuan et al., 2006; Neffling et al., 2010), and it has been applied to a range of matrices
including assessment of human exposure (e.g. Yuan et al., 2006). Accordingly, the MMPB
method represents a tremendous advancement to both our understanding of trophic transfer/
bioavailability of this toxin, as well as our ability to assess its role in food webs and bioaccu‐
mulation with respect to public health.
Similar to the covalent binding of MCs to PPase targets, the possible incorporation of BMAA
into proteins, and consequent potential for underestimation, has been addressed in recent –
albeit much fewer - studies. Incorporation of BMAA into proteins, with respect to both
analytical challenges, and its possible role in bioavailability and trophic transfer of the toxin,
was first reported by Murch et al. (2004). In this study, acid hydrolysis (i.e. 24 h boiling in 6 M
HCl) – to digest proteins, and release BMAA - coupled to subsequent HPLC-FL analysis
measured levels of the toxin in cycad flours exceeding those previously measured, following
simple solvent extraction (i.e. presumptively unbound BMAA), by as much as 90-fold. In the
same study, BMAA in brain tissues from patients who had died of Alzheimer’s Disease were,
likewise, analyzed following acid digestion, and similarly showed levels of the toxin that were
60- to 130-fold great than those measured following solvent extraction (i.e. “free BMAA” only).
The presence of this bound pool of BMAA in proteins was accordingly suggested to represent
a previously unrecognized reservoir of the toxin available for both trophic transfer (i.e.
following proteolytic enzyme digestion), and as a slowly released form of the toxin with respect
to the recurrent damage and “latency period” observed in the onset of these neurodegenerative
diseases (Murch et al., 2004). Moreover, these results point to a limitation in the prior analytical
approach, and specifically a likely underestimation of the toxin in food webs. Accordingly,
subsequent studies (Rosen and Hellenäs, 2008; Baptista et al., 2011; Cervantes Cianca et al.,
2012) have undertaken development and validation – as well as application - of various
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analytical techniques (e.g. HPLC-FL, LC-MS/MS and CE-UV) that incorporate acid hydrolysis
a means of characterizing “total BMAA” content. As these methods are validated, they will no
doubt provide a key tool for evaluating both the ecology (e.g. trophic transfer within food-
webs) and toxicology of this cyanobacterial metabolite, and clarify its possible role in human
health.
6. Other cyanobacterial toxins and their bioaccumulation
A rather limited number of secondary metabolites produced by cyanobacteria – as discussed
throughout this chapter (i.e. MCs, CYN, STX/PSTs, ATX-a and BMAA) – are generally
considered, specifically based on association with documented intoxication events, as “toxins.”
However, the blue-green algae are, in fact, widely recognized to produce a myriad of biolog‐
ically active metabolites (Gerwick et al., 2001; Tan, 2007; Tan, 2010). Rather than toxins though,
the majority of these chemically diverse, bioactive compounds have been identified as part of
“drug discovery” efforts (Tan, 2007). That said, many of the biological systems used to prospect
for potential pharmaceuticals – most notably perhaps including cytotoxicity as a means of
identifying anticancer drugs – could clearly be extended to include those compounds (i.e.
“cytotoxins”) which may have negative impacts on human health, as toxins, rather than, or in
addition to, their intended therapeutic targets. Indeed, it has been argued (e.g. Berry et al.,
2008) that many (or perhaps even most) of the bioactive secondary metabolites from cyano‐
bacteria – including several investigated as drug leads - are likely produced as allelelochemi‐
cals, serving a role as chemical agents for deterrence, specifically through their “toxicity,”
toward other organisms.
Although limited to no literature exists, due to the nature of their discovery (as drug candi‐
dates), on either the potential for either toxicity or bioaccumulation of these many previously
identified bioactive metabolites, indirect evidence suggests that as-of-yet unidentified
metabolites do, indeed, contribute to toxicity of the cyanobacteria. Specifically, several studies
(e.g. Pietsch et al., 2001; Kurmayer and Jüttner, 2009) have compared relative toxicity of pure
cyanobacterial toxins to crude extracts, and consistently found higher degrees of biological
activity for the latter suggesting an additive or even synergistic role of congeners in these
mixtures, including both chemically related (i.e. variants within a toxin family) and/or
potentially unrelated, and likely uncharacterized, metabolites. These finding, therefore,
generally point to the higher toxicity of metabolic mixtures, and specifically suggest the
possibility of unknown toxins which might be relevant to bioaccumulation – and, thus,
consequent health concerns - within food-webs. Identification of these additional toxic
metabolites will, therefore, be essential to a holistic understanding of the health effects of
cyanobacterial toxins, including their potential contribution to food-borne toxicity.
Due, perhaps in part, to the nature of the biological assays used (e.g. cytotoxicity assays,
enzyme inhibition assays) that rely on water-solubility of test compounds, the majority of the
bioactive metabolites identified from blue-green algae as potential drug candidates have
typically focused on rather water-soluble or polar compounds, and particularly the diverse
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non-ribosomal peptides (NRPs) characteristic of the cyanobacteria (Welker and Von Döhren,
2006). Indeed, a few such NRPs have, in fact, been identified alongside recognized toxins,
specifically based on potential relevance to chemical ecology. A particularly notable example
is the identification of several chemically related, and apparently quite widespread, peptides
– isolated, alongside MCs, from Microcystis - as protease inhibitors (e.g. microviridin J,
aeruginosin) with demonstrated ability to serve as feeding deterrents to the zooplankton,
Daphnia (Harada et al., 1993; Martin et al., 1993; Okino et al., 1993; Tsukamoto et al., 1993;
Rohrlack et al., 2004; von Elert et al., 2005). As for MCs, very recent studies suggest a genotype
x genotype interaction between toxin and grazer, and consequent development of tolerance
to these protease inhibitors (Schwarzenberger et al., 2012; von Elert et al., 2012). Accordingly,
these latter findings would open up the door to possible bioaccumulation, and possible human
exposure, although to-date there have not been any studies to investigate this aspect within
freshwater food-webs.
In marine environments, a particularly salient example is lyngbyatoxin, and severally chemi‐
cally related cyclic peptides (e.g. aplysiatoxin, debromoaplysiatoxin), isolated from marine
species of the genus, Lyngbya, a well known producer of several known cyanobacterial toxins
(i.e. MCs, CYN, STX/PSTs). Although these former peptide toxins, specifically acting as
activators of protein kinase C, have been associated with direct human exposure (i.e. derma‐
totoxins) – as well as being investigated with respect to possible pharmacological potential –
the toxins, found in filamentous cyanobacteria in marine shallows, have also been reported to
be incidentally grazed by marine animals, including invertebrates – and particularly various
species of gastropods that accumulate the toxin (Capper et al., 2005) - and vertebrates, most
notably including sea turtles (Yasumoto et al., 1998; Arthur et al., 2008). Given the recognized
toxicity to mammals (e.g. Ito et al., 2002), it is suggested that possible bioaccumulation, and
subsequent consumption, could represent a route of human exposure and toxicity. In fact, as
one of the few examples of acute toxicosis possibly associated with foodborne cyanotoxins,
the presence of these toxins in turtle meat has been linked (Yasumoto et al., 1998) to several
cases of human intoxication in the South Pacific and Madagascar (Hashimoto et al., 1967;
Champetier et al., 1998) specifically characterized by ulceration of mucosal membranes, as well
as apparent neurotoxic effects. It is also worth noting that these toxins have been hypothesized
(Arthur et al., 2008) to explain chronic health effects – and specifically promotion of tumors
associated with fibropapillomatosis – in exposed turtles, and these results, therefore, under‐
score the largely unstudied, possible contribution of these toxins to similar human health
concerns associated with long-term, food-borne exposure.
Although the vast majority of bioactive secondary metabolites identified have, for reasons
stated  above,  particularly  included  a  number  of  peptides  and  other  hydrophilic  com‐
pounds, the cyanobacteria are known to produce a variety of lipophilic metabolites as well.
In support of a possible role of these metabolites in relation to food webs, when evaluat‐
ing the effects  of  toxic  metabolites  from the recognized toxigenic cyanobacterial  species,
Planktothrix  rubescens,  Kurmayer  and  Jüttner  (1999)  observed  that  lipophilic  extraction
reduced feeding deterrence of the cyanobacterial  cells with respect to zooplankton graz‐
ers, and pointed to an uncharacterized lipophilic metabolite in this species. In more recent
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studies,  Berry  et  al.  (2009)  evaluated  non-polar  extracts  of  the  CYN-producing  species,
Aphanizomenon ovalisporum  and Cylindrospermopsis  raciborskii,  specifically using the zebra‐
fish embryo model, and identified apparent lipophilic toxins, chemically unrelated to CYN
or other water-soluble toxins produced by these species. It is not, therefore, surprising that
considerable research in this area has identified numerous lipophilic metabolites ranging
from alkaloids to lipopeptides (Orjala et al., 1995; Wu et al., 2000; Li et al., 2001; Edwards
et al., 2004) to fatty acids (e.g. polyunsaturated fatty acid [PUFAs], Reinikainen et al., 2001)
and seemingly simple hydrocarbons (Jaja-Chimedza et al., 2012).
Although much of the chemistry behind these observations remains to be characterized, one
particularly well-studied group of lipophilic metabolites is a diverse family of indole alkaloids
produced by members of the relatively widespread, but otherwise understudied, Stigonema‐
taceae (e.g. Raveh and Carmeli, 2007; Mo et al., 2010; Kim et al., 2012; and many more).
Although this chemically diverse, and taxonomically restricted, group of metabolites have
been generally identified based on antimicrobial activity (e.g. Raveh and Carmeli, 2007; Mo et
al., 2012), and in fact, have been linked to possible allelopathy (i.e. inhibition of photosynthetic
microbial competitors) in their natural environment, several biological activities supporting
animal toxicity have also been reported (e.g. inhibition of RNA polymerase; Doan et al.,
2001). This finding, and their seemingly widespread occurrence, raises the question as to
whether these quite lipophilic metabolites may contribution to toxicity within food webs,
including perhaps human health concerns.
Similarly, considerable work over the past 15 years or more has identified a diversity of
lipopeptides, particularly isolated from the widespread marine cyanobacterial species,
Lyngbya majuscula (Orjala et al., 1995; Orjala et al., 1996; Li et al., 2001; Nogle et al., 2001;
Edwards et al., 2004; Choi et al., 2010) and others (e.g. Anabaena; Kaya et al., 2002). Although
bioactivity associated with these metabolites runs the gamut from inhibition of specific
enzymes to cytotoxicity in mammalian cells to toxicity in a range of organisms (e.g. antifungal,
molluscicidal, ichthyotoxicity), potent neurotoxicity has, in particular, been associated with a
number of these (e.g. Li et al., 2001; Nogle et al., 2001; Edwards et al., 2004; Choi et al., 2010).
However, although a wealth of information regarding toxicity has emerged alongside their
chemical discovery, essentially no insight as to possible bioaccumulation – despite the global
abundance of these taxa, e.g. Lyngbya, in marine and freshwater habitats – currently exists.
More recently – following-up on prior studies (Berry et al., 2009; as discussed briefly above) –
an apparently widespread group of toxic, lipophilic metabolites have been identified from
several species of otherwise toxigenic cyanobacteria. Utilizing the zebrafish (Danio rerio)
embryo as a vertebrate model of so-called developmental toxicity, and specifically as a means
of bioassay-guided fractionation, Jaja-Chimedza et al. (2012), in very recent studies, identified a
family of isotactic polymethoxy-1-alkenes (PMAs) from Aphanizomenon ovalisporum, specifi‐
cally as lipophilic inhibitors of developmental pathways in this model system. Both this
species, and the genus (i.e. Aphanizomenon), more generally, are recognized producers of CYN
(genus/species; e.g. Preussel et al., 2006), as well as the neurotoxic STX/PSTs and ATX-a
(species; e.g. Mahmood and Carmichael, 1986 and Ballot et al, 2010, respectively). The
identification of PMAs as lipophilic metabolites in this species, including CYN-producing
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strains (Berry et al., 2009), suggests that they may contribute to the overall toxicity of this widely
distributed species, as well as - given the highly lipid-soluble nature of these compounds - the
potential for their bioaccumulation, and even biomagnfication, within food-webs. Moreover,
prior studies have identified the same or similar PMAs from a wide range of cyanobacteria
(e.g. Mynderse and Moore, 1979; Mori et al., 1991), although previous studies did not originally
link their presence to potential toxicity (but rather identified them based on chemical charac‐
terization), and subsequent studies (Jaja-Chimedza et al., forthcoming), using the same
toxicity, have identified them in otherwise recognized toxigenic species (e.g. C. raciborkskii, M.
aeruginosa). These emerging findings suggest that this group of metabolites may be wide‐
spread, and further underscore the potential role in food-derived toxicity. In fact, identification
of closely related metabolites in marine sponges (Rama and Faulkner, 2002) has been attributed
to a cyanobacterial biosynthetic origin/source (likely via filter-feeding of algal cells), and
further support the potential for their uptake and accumulation in higher trophic levels. To-
date, however, studies on their bioaccumulation (beyond this example) in food-webs remains
to be addressed.
7. Implications for ecosystem health
Finally, although beyond the scope of this chapter (and volume), it is worthwhile to consider
– before concluding our discussion with respect to public health implications of cyanobacterial
toxins in food webs – the apparent contribution of cyanobacterial toxins in food webs with
respect to animal and ecosystem health. Obviously, understanding the impacts of these toxins
on animal health with respect to ecosystems is essential to understanding the potential for
trophic transfer of these toxins. Moreover, insights regarding the potential for human health
concerns of food-borne toxins – especially as contaminants of shared food-webs - can be often
studied indirectly, and to some extent extrapolated, by understanding the role of these toxins
in non-human animals. Indeed, with regards to the toxicity of cyanobacterial metabolites, the
first reported case of intoxication by a cyanobacterial bloom was made based on animal health,
and specifically reported livestock poisonings associated with pond scums (later identified as
cyanobacteria) in a so-called “poisonous lake,” famously detailed in the pioneering works by
George Francis in the late 19th century (Francis, 1878).
Given that current evidence generally suggests limited trophic transfer of most of the known
cyanobacterial toxins, and consequent restriction of foodborne cyanobacterial toxins to lower
trophic levels in food-webs, it is not surprising that toxicity to animals has particularly focused
on those vertebrate (i.e. fish) and invertebrates which are exposed either directly (through
phytoplanktivory), or through “single vector” (e.g. zooplanktivory), transfer. For example, the
previously discussed studies of Karjalainen et al. (2005), not only demonstrated that pre-
exposure of zooplankton to cell-free, NOD-containing extracts of N. spumigens – representative
of the toxin released during blooms –resulted in subsequent bioaccumulation of this toxin in
zooplanktivorous, larval fish predators, but also decreased (compared to unexposed controls)
ingestion, growth rate and fecal production of the experimentally fed zooplanktivorous larvae
of Northern Pike (Esox lucius), suggesting a possible toxic effect to these predators without
Current Topics in Public Health568
direct exposure to the toxin-containing water or algal cells. Interestingly enough, no such
statistically significant effects was observed for larvae fed zooplankton which were pre-
exposed to pure NOD, suggesting a possible contribution of other, currently unknown, toxins
(Karjalainen et al., 2005).
Numerous studies, encompassing essentially all of the other known cyanotoxins, as well as
yet uncharacterized, but apparently toxic, metabolites, likewise, have demonstrated the
potential toxic effects to various aquatic species exposed at this lower end of the trophic scale.
At the level of zooplanktivorous grazers, numerous studies have documented the apparent
toxic effects of, not only MCs (as discussed above), but also other cyanobacterial toxins,
including CYN (Nogueira et al., 2004), STX/PSTs (Filho et al., 2008) and ATX-a (Sieroslawska
et al., 2010) - as well as perhaps other unidentified metabolites (present in extracts) - on Daphnia,
and various other species. Likewise, biochemical and histopathologic analyses of both benthic
grazers, particularly including snail species (Lance et al., 2010), and filter-feeding bivalves
(Puerto et al., 2011; Sabatini et al., 2011), exposed to cell-bound toxins, including MCs and
CYN, as well as unidentified toxic metabolites, demonstrate toxicity – along with apparent
bioaccumulation – corresponding to uptake and transport pathways from the digestive
system. Similarly, toxicity of several cyanobacterial metabolites to fish – and particularly
several, representative phytoplanktivorous species (e.g. carp, tilapia) - exposed to dietary
sources of these toxins has been well documented (e.g. Jos et al., 2005; Osswald et al., 2007; El
Ghazali et al., 2010; Qiao et al., 2012).
On the other hand, relatively fewer studies to-date have clearly documented toxic effects of
subsequent predation on toxin-laden invertebrates (e.g. zooplankton, benthic invertebrates),
or phytoplanktivorous fish. However, the limited studies that have do generally point to the
potential for toxicity – along with toxin transfer – to higher trophic levels. In one particularly
notable study, Qiu et al. (2007) examined – using biochemical and histopathological ap‐
proaches - four trophic levels, comprised of a phytoplanktivorous, omnivorous and carnivo‐
rous fish species in a Chinese lake in relation to a MC-producing bloom. Surprisingly in this
case, the most pronounced histopathological signs of toxicity were observed for carnivorous
fish, whereas the largest biochemical response (i.e. particularly the production of several
antioxidant enzymes/pathway, e.g. superoxide disumutase, catalase, glutathione, glutathione
peroxidase), were measured for phytoplanktivorous species. These results suggest not only
that carnivores can be exposed to cyanobacterial metabolites, and toxic effects via food webs,
but that grazers of cyanobacteria (i.e. phytoplanktivores) may, as such, be specifically adapted
to the direct exposure to these toxins.
The toxic effects of cyanobacterial metabolites on higher trophic levels, aside from fish, in
aquatic food webs remain quite scarce, despite the fact that numerous taxa, including bird
and mammalian  species,  are  recognized  as  frequent  “top  consumers”  in  these  systems.
However, examples are beginning to emerge in the literature.  In an especially insightful
example,  Miller  et  al.  (2010)  recently  reported  on  the  apparent  toxic  effects  -  including
several animal deaths among - among southern sea otters,  along the Pacific coast of the
U.S.,  exposed  to  MCs  bioaccumulated  by  bivalves  (i.e.  clams,  mussels  and  oysters)
consumed by these carnivorous predators. Following an unusually high number of sea otters
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deaths in the Monterey Bay, and surrounding coastal areas, particularly during the period
of 2005-2008, necropsy on these stranded animals was performed. Based on the detection
of relatively high levels (up to 348 ppb) of several variants of microcystins, including MC-
RR,  -LR  and  -desmethyl  LR,  in  livers  of  sea  otters,  along  with  gross  and  microscopic
pathological  indications  -  particularly  in  livers  of  the  animals  -  consistent  with  MC
intoxication,  it  was  concluded  that  animals  had,  indeed,  died  from  exposure  to  this
cyanobacterial  toxin.  The source of  the toxin was ultimately traced to outflow from the
nearby Pinto Lake into the marine waters of Monterey Bay, and subsequent bioaccumula‐
tion of the toxin by mollusks, consumed by sea otters, in the Bay. Characterized as a “super-
bloom” of cyanobacteria, levels of MC in Pinto Lake, during this time, were measured as
high as 2,100 ppm (more than six orders of magnitude higher than the WHO limit of 1
ppb), and use of Solid Phase Adsorption Toxin Tracking (SPATT) samples enabled tracking
of the toxin from the lake toward the Bay. Subsequent laboratory studies confirmed the
bioaccumulation of MC - at levels as high 1,324 ppb - by various bivalve (i.e. clam, mussel,
oyster) species that make up a primary component of the sea otters’ diet. Indeed, this case
is  particularly  revealing  as  it  not  only  supports  hypothesis  that  higher  trophic  levels  –
including mammalian carnivores - can, in fact, be exposed to toxic (and even lethal) levels
of cyanobacterial toxins through food-webs, but also that toxins can transfer not only within
ecocystems,  but  between  (in  this  case,  freshwater  and  marine)  systems.  Moroever,  al‐
though levels of MCs, in this case, were exceptionally high, this study further provides –
through quantificationof  the  toxin  in  (livers  of)  exposed  animals  –  a  first  estimation  of
relevant (i.e. lethal) exposure doses for mammalian consumers in relation to environmen‐
tal concentration both in water, and vectors (i.e. bioaccumulation in bivalves) of the toxin.
8. Conclusions
Cyanobacteria are prolific producers of toxic, and otherwise biologically (i.e. pharmacologi‐
cally) active, metabolites. Although ubiquitous in the environment, the cyanobacteria are
arguably most conspicuous, and generally more abundant, in aquatic systems, particularly in
association with so-called “harmful algal blooms.” As such, exposure to several cyanobacterial
toxins through contamination of drinking water, and related routes, has been clearly linked to
both acute toxicoses, including human and animal mortalities, as well as being increasingly
tied to several long-term health effects (e.g. cancer, neurodegenerative disease). Consequently,
waterborne cyanotoxins are widely acknowledged as a global health concern.
Given this particularly widespread occurrence of the “blue-green algae” in marine and
freshwater ecosystems, it is not, therefore, surprising, that bioaccumulation of nearly all of the
“recognized” cyanobacterial toxins within relevant species of aquatic food webs has been
reported. In light of the enormous human reliance on the world’s oceans and freshwater
systems, particularly as a source of food (i.e. fish, seafood), as well as culminating evidence to
suggest that global climate change is fueling an apparently rapid increase in cyanobacterial
abundance, bloom frequency and perhaps even toxigenicity in aquatic systems, cyanobacterial
toxins in food webs, likewise, represent a clearly important human health issue.
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As an emerging concern, however, clearly more questions than answers remain, at present,
regarding the potential role of cyanobacterial toxins in food webs, particularly in terms of
possible  human  and  environmental  health  concerns.  Although  a  preponderance  of  evi‐
dence indicates that diverse taxa of aquatic animal species do, in fact, accumulate cyanotox‐
ins,  the  biochemical,  physiological  and ecological  processes  that  control  trophic  transfer
within food-webs remains to be clarified. Likewise, although trophic transfer of the largely
water-soluble  “known” cyanobacterial  toxins  appears  to  follow a  pattern of  biodilution,
rather  than  biomagnification  to  top  consumers,  a  growing  number  cases  indicate  that
species,  known  to  be  consumed  as  part  of  human  diets,  do  bioaccumulate  significant
quantities of these toxins,  yet the potential  implications for human health remains to be
elucidated. This, it is argued is due, in part, to the lack of information regarding bioavaila‐
bility,  as  well  as  limitations  and challenges  in  current  analytical  methodologies  used to
assess this contribution.
Although the scientific evidence that does exist strongly suggests a potential (and, in fact,
high probability) for human exposure to, and consequent health concerns associated with,
food-borne  cyanobacterial  toxins,  the  implications  with  respect  to  public  health  policy
remains almost entirely to be addressed. Indeed, while our scientific understanding of the
bioaccumulation  of  cyanobacterial  toxins  in  relation  to  human health  currently  remains
rather  limited -  particularly relative to many other environmental  health concerns –  the
public health implications, including relevance to policy makers and stakeholders, lags even
more so. And, in fact, it is asserted that it is many of the same gaps in knowledge that limit
our scientific understanding which, likewise, limit public health policy with regards to food-
borne cyanotoxins, and thus addressing these gaps will be critical in this regard. First, and
perhaps  foremost,  is  the  preeminent  need  to  understand  the  toxicology  of  food-borne
cyanotoxins, including both laboratory and (currently non-existent) epidemiological studies
to elucidate what (if any) health effects exist, and which groups are most likely affected.
Similarly, clarifying the actual health effects, including relevant doses, mechanisms of action,
bioavailability,  etc.,  will  be  fudnamental  to  developing  effective  regulatory  guidelines.
Although, as described above, attempts have been made (e.g. Ibelings and Chorus, 2007)
to  extrapolate  current  (albeit  limited)  toxicological  knowledge in  this  regard to  possible
acceptable levels for food-borne cyanotoxins, these are based entirely on data from water-
borne toxins, and are not likely to be accurate in terms of exposure through food. Further‐
more, even the provisional guidelines that exist for cyanobacterial toxins in water are only
recommendations, and policy will not only need to clarify acceptable levels, but also address
monitoring and enforcement of these guidelines.  As such, improvements, validation and
standardization of methods for chemical analysis of cyanobacterial toxins – toward effective
monitoring and enforcement - in food will be key. Continued investigations in these areas
will, therefore be of the crucial toward developing a comprehensive picture of this emerging
public health concern.
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